00000000|MMI|185.95|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-53-"DISCHARGE"-noun-0,"Discharge"-tx-51-"DISCHARGE"-noun-0,"Discharge"-tx-44-"discharge"-noun-0,"Discharge"-tx-34-"discharge"-noun-0,"Discharge"-tx-32-"discharge"-noun-0,"Discharge"-tx-21-"discharge"-noun-0,"Discharge"-tx-20-"discharge"-noun-0,"Discharge"-tx-7-"DISCHARGE"-noun-0,"Release"-tx-5-"RELEASE"-adj-0,"Discharge"-tx-3-"DISCHARGE"-verb-0,"Patient Discharge"-tx-2-"DISCHARGE PATIENT"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|8719/9;8267/9;7373/9;6469/9;6118/9;5207/9;5120/9;3186/9;2650/7;455/9;239/17;165/9|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|153.22|Portugal|C0032729|[geoa]|["PO"-tx-20-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|[5065/2],[5087/2];[1459/2],[1925/2],[2157/2],[2319/2],[2462/2],[2503/2];[1045/2],[1095/2],[1159/2],[1251/2];[517/2],[581/2],[695/2],[731/2]|Z01.542.727
00000000|MMI|125.61|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-48-"Pt"-noun-0,"PT"-tx-47-"Pt"-noun-0,"PT"-tx-45-"Pt's"-noun-0,"PT"-tx-43-"Pt"-noun-0,"PT"-tx-41-"Pt"-noun-0,"PT"-tx-39-"pt's"-noun-0,"PT"-tx-36-"Pt"-noun-0,"PT"-tx-33-"Pt"-noun-0,"PT"-tx-32-"pt"-noun-0,"PT"-tx-31-"Pt"-noun-0,"PT"-tx-28-"Pt"-noun-0,"PT"-tx-27-"pt"-noun-0,"PT"-tx-26-"Pt"-noun-0,"PT"-tx-25-"Pt"-noun-0,"PT"-tx-20-"Pt"-noun-0,"PT"-tx-19-"pt"-noun-0,"PT"-tx-12-"pt"-noun-0,"PT"-tx-11-"Pt"-noun-0]|TX|7755/2;7606/2;7390/4;7303/2;7036/2;6873/4;[6523/2],[6598/2];6301/2;6148/2;6037/2;5837/2;5750/2;5609/2;5558/2;4912/2;4868/2;4212/2;4092/2|
00000000|MMI|125.61|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-48-"Pt"-noun-0,"PT"-tx-47-"Pt"-noun-0,"PT"-tx-45-"Pt's"-noun-0,"PT"-tx-43-"Pt"-noun-0,"PT"-tx-41-"Pt"-noun-0,"PT"-tx-39-"pt's"-noun-0,"PT"-tx-36-"Pt"-noun-0,"PT"-tx-33-"Pt"-noun-0,"PT"-tx-32-"pt"-noun-0,"PT"-tx-31-"Pt"-noun-0,"PT"-tx-28-"Pt"-noun-0,"PT"-tx-27-"pt"-noun-0,"PT"-tx-26-"Pt"-noun-0,"PT"-tx-25-"Pt"-noun-0,"PT"-tx-20-"Pt"-noun-0,"PT"-tx-19-"pt"-noun-0,"PT"-tx-12-"pt"-noun-0,"PT"-tx-11-"Pt"-noun-0]|TX|7755/2;7606/2;7390/4;7303/2;7036/2;6873/4;[6523/2],[6598/2];6301/2;6148/2;6037/2;5837/2;5750/2;5609/2;5558/2;4912/2;4868/2;4212/2;4092/2|
00000000|MMI|110.17|Togo|C0040363|[geoa]|["TO"-tx-43-"to"-adv-0,"TO"-tx-42-"to"-adv-0,"TO"-tx-40-"to"-adv-0,"TO"-tx-36-"to"-adv-0,"TO"-tx-33-"to"-adv-0,"TO"-tx-32-"to"-adv-0,"TO"-tx-27-"to"-adv-0,"TO"-tx-19-"to"-adv-0,"TO"-tx-5-"to"-adv-0]|TX|7319/2;7274/2;7011/2;6611/2;6358/2;6230/2;5753/2;4755/2;2731/2|Z01.058.290.190.800
00000000|MMI|110.17|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-43-"to"-adv-0,"TO"-tx-42-"to"-adv-0,"TO"-tx-40-"to"-adv-0,"TO"-tx-36-"to"-adv-0,"TO"-tx-33-"to"-adv-0,"TO"-tx-32-"to"-adv-0,"TO"-tx-27-"to"-adv-0,"TO"-tx-19-"to"-adv-0,"TO"-tx-5-"to"-adv-0]|TX|7319/2;7274/2;7011/2;6611/2;6358/2;6230/2;5753/2;4755/2;2731/2|D08.811.520.224.800
00000000|MMI|84.31|Homo sapiens|C0086418|[humn]|["Human"-tx-5-"HUMAN"-noun-0,"Human"-tx-3-"HUMAN"-noun-0]|TX|[1401/5],[2396/5],[2528/5];603/5|B01.050.150.900.649.801.400.112.400.400
00000000|MMI|60.20|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-51-"ASA"-noun-0,"ASPIRIN"-tx-49-"aspirin"-noun-0,"ASA"-tx-30-"ASA"-noun-0]|TX|8613/3;8013/7;5999/3|D02.455.426.559.389.657.410.595.176
00000000|MMI|57.35|Dominican Republic|C0013014|[geoa]|["DR"-tx-49-"Dr"-noun-0,"DR"-tx-43-"Dr"-noun-0,"DR"-tx-31-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|8098/2;7342/2;6087/2;3038/2;2988/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|56.23|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-36-"SC"-noun-0,"SC"-tx-5-"SC"-noun-0,"SC"-tx-3-"SC"-noun-0]|TX|6554/2;[1420/2],[2439/2],[2573/2];645/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|56.09|Physicians|C0031831|[prog]|["Doctor"-tx-50-"doctor"-noun-0,"DR"-tx-49-"Dr"-noun-0,"DR"-tx-43-"Dr"-noun-0,"DR"-tx-31-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|8246/6;8098/2;7342/2;6087/2;3038/2;2988/2|M01.526.485.810;N02.360.810
00000000|MMI|54.43|Oral|C0442027|[spco]|["PO"-tx-20-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|[5065/2],[5087/2];[1459/2],[1925/2],[2157/2],[2319/2],[2462/2],[2503/2];[1045/2],[1095/2],[1159/2],[1251/2];[517/2],[581/2],[695/2],[731/2]|
00000000|MMI|53.41|Regular Insulin, Human|C0795635|[aapp,horm,phsu]|["INSULIN HUMAN"-tx-5-"INSULIN HUMAN"-noun-0,"INSULIN HUMAN"-tx-3-"INSULIN HUMAN"-noun-0]|TX|[2406/7,2422/5],[2538/7,2554/5];613/7,627/5|D06.472.699.587.200.500.625.500;D12.644.548.586.200.500.625.500
00000000|MMI|53.34|Zocor|C0678181|[orch,phsu]|["Zocor"-tx-51-"zocor"-noun-0,"Zocor"-tx-49-"Zocor"-noun-0,"Zocor"-tx-4-"ZOCOR"-noun-0]|TX|8571/5;7971/5;1245/5|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|46.92|Cozaar|C0591301|[orch,phsu]|["Cozaar"-tx-51-"cozaar"-noun-0,"Cozaar"-tx-49-"cozaar"-noun-0,"Cozaar"-tx-23-"Cozaar"-noun-0]|TX|8579/6;7979/6;5417/6|D02.455.426.559.389.185.475;D03.383.129.308.507;D03.383.129.617.467
00000000|MMI|46.56|Insulin|C0021641|[aapp,horm,phsu]|["INSULIN"-tx-5-"INSULIN"-noun-0,"Insulin, Regular"-tx-5-"REGULAR INSULIN"-noun-0]|TX|1385/7;[2378/15],[2510/15]|D06.472.699.587.200.500.625;D12.644.548.586.200.500.625
00000000|MMI|46.33|Atrial Fibrillation|C0004238|[dsyn]|["AFib"-tx-19-"afib"-noun-1,"AFib"-tx-18-"AFib"-noun-0,"AFib"-tx-7-"AFib"-noun-0,"ATRIAL FIBRILLATION"-tx-7-"atrial fibrillation"-noun-0]|TX|4716/4;4529/4;3698/4;[3413/19],[3435/19]|C14.280.067.198;C23.550.073.198
00000000|MMI|46.25|Levofloxacin|C0282386|[antb,orch]|["LEVOFLOXACIN"-tx-5-"LEVOFLOXACIN"-noun-0]|TX|[2007/12],[2144/12],[2239/12]|D03.438.810.835.322.500.500
00000000|MMI|45.13|Mongolia|C0026410|[geoa]|["MG"-tx-5-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0,"MG"-tx-3-"MG"-noun-0]|TX|2316/2;1042/2;[514/2],[578/2],[728/2]|Z01.252.474.651
00000000|MMI|44.93|Hematocrit procedure|C0018935|[lbpr]|["HCT"-tx-51-"Hct"-noun-0,"HCT"-tx-29-"HCT"-noun-0,"HCT"-tx-28-"HCT"-noun-0,"HCT"-tx-15-"HCT"-noun-0]|TX|8415/3;5967/3;5858/3;4349/3|E01.370.225.625.400;E05.200.625.400;G09.188.370.374
00000000|MMI|44.93|Hemopoietic stem cell transplant|C0472699|[topp]|["HCT"-tx-51-"Hct"-noun-0,"HCT"-tx-29-"HCT"-noun-0,"HCT"-tx-28-"HCT"-noun-0,"HCT"-tx-15-"HCT"-noun-0]|TX|8415/3;5967/3;5858/3;4349/3|E04.936.225.687.500
00000000|MMI|39.17|Override|C1547671|[acty]|["Override"-tx-5-"Override"-verb-0,"Override"-tx-5-"override"-verb-0,"Override"-tx-4-"Override"-verb-0,"Override"-tx-4-"override"-verb-0,"Override"-tx-3-"Override"-verb-0,"Override"-tx-3-"overridden"-noun-0]|TX|[1825/8],[1842/8],[2081/8];[1353/8],[2031/8],[2059/8],[2263/8];[1165/8],[1182/8];989/8;787/8;775/10|
00000000|MMI|36.76|Celebrex|C0719198|[orch,phsu]|["Celebrex"-tx-51-"celebrex"-noun-0,"Celebrex"-tx-49-"celebrex"-noun-0,"Celebrex"-tx-35-"celebrex"-noun-0]|TX|8588/8;7988/8;6485/8|D02.065.884.247;D02.886.590.700.247;D03.383.129.539.160
00000000|MMI|36.76|Tylenol|C0699142|[orch,phsu]|["Tylenol"-tx-51-"tylenol"-noun-0,"Tylenol"-tx-49-"tylenol"-noun-0,"Tylenol"-tx-41-"tylenol"-noun-0]|TX|8550/7;7950/7;7085/7|D02.065.199.092.040
00000000|MMI|36.30|Liver Function Tests|C0023901|[lbpr]|["LFT"-tx-51-"LFT"-noun-0,"LFT"-tx-42-"lft's"-noun-0,"LFT"-tx-39-"LFT's"-noun-0,"LFT"-tx-37-"LFT's"-noun-0]|TX|8324/3;7262/5;6878/5;6663/5|E01.370.372.460
00000000|MMI|36.14|Diet|C0012155|[food]|["Dietary"-tx-11-"dietary"-adj-0,"Diet"-tx-5-"DIET"-noun-0]|TX|4161/7;[2804/4],[2838/4],[2906/4]|G07.203.650.240
00000000|MMI|35.42|Weight Gain|C0043094|[fndg]|["Gain, Weight"-tx-9-"weight gain"-noun-0,"Gain, Weight"-tx-7-"weight gain"-noun-0]|TX|4003/11;3771/11|C23.888.144.243.926;G07.700.320.249.314.120.200.926
00000000|MMI|35.13|Diurese|C0719972|[orch,phsu]|["Diurese"-tx-20-"diuresed"-adj-0,"Diurese"-tx-8-"diuresed"-verb-0]|TX|4926/8;3830/8|D02.886.590.700.135.261.476.716;D02.886.655.500.261.476.716;D03.438.174.261.476.716
00000000|MMI|33.66|Daily|C0332173|[tmco]|["/day"-tx-45-"day"-noun-0,"Daily"-tx-22-"daily"-noun-0,"/day"-tx-21-"day"-noun-0,"/day"-tx-20-"day"-noun-0,"/day"-tx-12-"day"-noun-0,"Daily"-tx-5-"daily"-adj-0,"QD"-tx-4-"QD"-noun-0,"QD"-tx-3-"QD"-noun-0]|TX|7471/3;5331/5;5200/3;5107/3;4185/3;2798/5;[1048/2],[1098/2],[1162/2];[520/2],[584/2],[698/2]|
00000000|MMI|33.64|Continuous Positive Airway Pressure|C0199451|[topp]|["CPAP"-tx-27-"CPAP"-noun-0,"CPAP"-tx-27-"cpap"-noun-0]|TX|[5686/4],[5765/4];5717/4|E02.041.625.790.259;E02.880.820.790.259
00000000|MMI|33.10|isoniazid|C0022209|[orch,phsu]|["ISONIAZID"-tx-5-"INH"-noun-0]|TX|[1622/3],[1817/3],[2355/3]|D02.442.436;D03.066.349.410;D03.383.725.394.582
00000000|MMI|33.04|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-51-"ASA"-noun-0,"ASA"-tx-30-"ASA"-noun-0]|TX|8613/3;5999/3|D08.811.277.352.827.070.250
00000000|MMI|33.04|Narcotics|C0027415|[hops,phsu]|["Narcotics"-tx-4-"NARCOTICS"-noun-0]|TX|[887/9],[952/9]|D27.505.696.277.600;D27.505.696.663.850.014.760;D27.505.954.427.040.550;D27.505.954.427.210.600
00000000|MMI|33.04|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-7-"DIAGNOSIS"-noun-0]|TX|[3148/9],[3278/9]|x.x.x.x.x.x.x
00000000|MMI|30.76|1+|C3816745|[fndg]|["1+"-tx-51-"1"-integer-0,"1+"-tx-49-"1"-integer-0,"1+"-tx-34-"1"-real_number-1,"1+"-tx-28-"1"-integer-0,"1+"-tx-5-"1"-integer-0,"1+"-tx-4-"1"-integer-0,"1+"-tx-3-"1"-integer-0]|TX|8307/1;7908/1;6454/1;5827/1;[1517/1],[1699/1],[1810/1],[2491/1];1153/1;[506/1],[551/1]|
00000000|MMI|30.76|1+ Score|C2827734|[qnco]|["1+"-tx-51-"1"-integer-0,"1+"-tx-49-"1"-integer-0,"1+"-tx-34-"1"-real_number-0,"1+"-tx-28-"1"-integer-0,"1+"-tx-5-"1"-integer-0,"1+"-tx-4-"1"-integer-0,"1+"-tx-3-"1"-integer-0]|TX|8307/1;7908/1;6454/1;5827/1;[1517/1],[1699/1],[1810/1],[2491/1];1153/1;[506/1],[551/1]|
00000000|MMI|30.76|1+ Score, WHO|C2981698|[clas]|["1+"-tx-51-"1"-integer-0,"1+"-tx-49-"1"-integer-0,"1+"-tx-34-"1"-real_number-0,"1+"-tx-28-"1"-integer-0,"1+"-tx-5-"1"-integer-0,"1+"-tx-4-"1"-integer-0,"1+"-tx-3-"1"-integer-0]|TX|8307/1;7908/1;6454/1;5827/1;[1517/1],[1699/1],[1810/1],[2491/1];1153/1;[506/1],[551/1]|
00000000|MMI|30.72|Coding|C0009219|[ocac]|["code"-tx-3-"CODE"-noun-0,"code"-tx-3-"code"-noun-0]|TX|402/4;420/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|30.71|Body Weight|C0005910|[orga]|["Weight"-tx-22-"weight"-noun-0,"Weight"-tx-5-"weight"-noun-0]|TX|5337/6;2791/6|C23.888.144;E01.370.600.115.100.160.120;E05.041.124.160.750;G07.100.100.160.120;G07.700.320.249.314.120
00000000|MMI|30.50|Hospital admission|C0184666|[hlca]|["Admission"-tx-36-"admission"-adj-0,"admitted"-tx-33-"admitted"-verb-0,"Admission"-tx-29-"admission"-noun-0,"admitted"-tx-28-"admitted"-verb-0,"Admission"-tx-22-"admission"-noun-0,"Admission"-tx-21-"admission"-noun-0,"Admit"-tx-21-"admit"-verb-0,"Admission"-tx-12-"admission"-noun-0,"admitted"-tx-8-"Admitted"-adj-0,"Admission"-tx-7-"Admission"-noun-0,"Admit"-tx-7-"ADMIT"-verb-0]|TX|6637/9;6308/8;5983/9;5844/8;5304/9;5168/9;5284/5;4200/9;3785/8;3243/9;3142/5|
00000000|MMI|30.25|Allopurinol|C0002144|[orch,phsu]|["ALLOPURINOL"-tx-51-"allopurinol"-noun-0,"ALLOPURINOL"-tx-49-"allopurinol"-noun-0,"ALLOPURINOL"-tx-41-"allopurinol"-noun-0]|TX|8599/11;7999/11;7115/11|D03.438.759.160
00000000|MMI|30.15|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-48-"CHF"-noun-0,"CHF"-tx-19-"CHF"-noun-0,"CHF"-tx-18-"CHF"-noun-0,"CHF"-tx-12-"CHF"-noun-0,"CHF"-tx-7-"CHF"-noun-0,"CHF"-tx-7-"chf"-noun-0,"CONGESTIVE HEART FAILURE"-tx-7-"congestive heart failure"-noun-0,"CHF"-tx-1-"chf"-noun-0]|TX|7864/3;4654/3;[4523/3],[4567/3];4227/3;3657/3;[3159/3],[3255/3],[3355/3];3361/24;65/3|
00000000|MMI|27.39|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-53-"DISCHARGE"-noun-0,"Discharge"-tx-51-"DISCHARGE"-noun-0,"Discharge"-tx-44-"discharge"-noun-0,"Discharge"-tx-34-"discharge"-noun-0,"Discharge"-tx-32-"discharge"-noun-0,"Discharge"-tx-21-"discharge"-noun-0,"Discharge"-tx-20-"discharge"-noun-0,"Discharge"-tx-7-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|8719/9;8267/9;7373/9;6469/9;6118/9;5207/9;5120/9;3186/9;455/9;165/9|
00000000|MMI|27.39|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-53-"DISCHARGE"-noun-0,"Discharge"-tx-51-"DISCHARGE"-noun-0,"Discharge"-tx-44-"discharge"-noun-0,"Discharge"-tx-34-"discharge"-noun-0,"Discharge"-tx-32-"discharge"-noun-0,"Discharge"-tx-21-"discharge"-noun-0,"Discharge"-tx-20-"discharge"-noun-0,"Discharge"-tx-7-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|8719/9;8267/9;7373/9;6469/9;6118/9;5207/9;5120/9;3186/9;455/9;165/9|
00000000|MMI|27.18|Dyspnea|C0013404|[sosy]|["SHORTNESS OF BREATH"-tx-50-"shortness of breath"-noun-0,"DYSPNOEA"-tx-18-"dyspnea"-noun-0,"SOB"-tx-10-"SOB"-noun-1]|TX|8141/19;4612/7;4086/3|C08.618.326;C23.888.852.371
00000000|MMI|26.87|Flonase|C0286677|[orch,phsu]|["Flonase"-tx-26-"flonase"-noun-0,"Flonase"-tx-5-"FLONASE"-noun-0]|TX|5647/7;1576/7|D04.808.054.079.129.114
00000000|MMI|26.79|Awareness|C0004448|[menp]|["Aware"-tx-5-"aware"-adj-0,"Aware"-tx-4-"aware"-adj-0]|TX|[1363/5],[2044/5];1002/5|F02.463.188.150
00000000|MMI|26.71|Rabbi|C0684010|[prog]|["R."-tx-19-"r"-adj-0,"R."-tx-7-"R"-noun-0]|TX|[4683/1],[4871/1];3580/1|M01.526.799.500
00000000|MMI|26.46|Salmeterol xinafoate|C0245531|[orch,phsu]|["SALMETEROL XINAFOATE"-tx-5-"SALMETEROL XINAFOATE"-noun-0]|TX|[1980/20],[2212/20]|D02.033.100.291.057.750;D02.092.063.291.057.750;D02.092.471.683.061.750
00000000|MMI|26.36|Phenanthrenes|C0031368|[orch,phsu]|["Phenanthrenes"-tx-4-"PHENANTHRENES"-noun-0]|TX|[899/13],[964/13]|D02.455.426.559.847.723;D04.615.723
00000000|MMI|26.10|To|C1883351|[qlco]|["To"-tx-43-"to"-adv-0,"To"-tx-42-"to"-adv-0,"To"-tx-40-"to"-adv-0,"To"-tx-36-"to"-adv-0,"To"-tx-33-"to"-adv-0,"To"-tx-32-"to"-adv-0,"To"-tx-27-"to"-adv-0,"To"-tx-19-"to"-adv-0,"To"-tx-5-"to"-adv-0]|TX|7319/2;7274/2;7011/2;6611/2;6358/2;6230/2;5753/2;4755/2;2731/2|
00000000|MMI|24.40|Ascorbic Acid|C0003968|[orch,phsu,vita]|["ASCORBIC ACID"-tx-3-"ASCORBIC ACID"-noun-0,"VITAMIN C"-tx-3-"VITAMIN C"-noun-0]|TX|490/13;478/9|D02.241.081.844.107;D02.241.511.902.107;D09.811.100
00000000|MMI|24.15|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-7-"ALLERGY"-noun-0,"ALLERGY"-tx-4-"ALLERGY"-noun-0,"Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|3078/7;[857/7],[922/7];[870/11],[935/11]|C20.543
00000000|MMI|23.73|Fatigue|C0015672|[sosy]|["FATIGUE"-tx-50-"fatigue"-noun-0,"FATIGUE"-tx-9-"fatigue"-noun-0,"FATIGUE"-tx-7-"fatigue"-noun-0]|TX|8163/7;3970/7;3746/7|C23.888.369
00000000|MMI|23.49|Admission activity|C0809949|[hlca]|["Admission"-tx-36-"admission"-adj-0,"Admitted"-tx-33-"admitted"-verb-0,"Admission"-tx-29-"admission"-noun-0,"Admitted"-tx-28-"admitted"-verb-0,"Admission"-tx-22-"admission"-noun-0,"Admission"-tx-21-"admission"-noun-0,"Admission"-tx-12-"admission"-noun-0,"Admitted"-tx-8-"Admitted"-adj-0,"Admission"-tx-7-"Admission"-noun-0]|TX|6637/9;6308/8;5983/9;5844/8;5304/9;5168/9;4200/9;3785/8;3243/9|
00000000|MMI|22.48|Rheumatic Fever|C0035436|[dsyn]|["ARF"-tx-51-"ARF"-noun-0,"ARF"-tx-35-"ARF"-noun-0]|TX|8523/3;6510/3|C01.252.410.890.731;C05.550.114.843;C05.799.825
00000000|MMI|22.31|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-14-"EKG"-noun-0,"EKG"-tx-5-"EKG"-noun-0]|TX|4302/3;2285/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|22.31|Electrocardiography|C1623258|[diap]|["EKG"-tx-14-"EKG"-noun-0,"EKG"-tx-5-"EKG"-noun-0]|TX|4302/3;2285/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|22.20|Hepatitis A|C0019159|[dsyn]|["Hepatitis"-tx-51-"hepatitis"-noun-0,"Hepatitis"-tx-38-"hepatitis"-noun-1]|TX|8340/9;6790/9|C02.440.420;C02.782.687.359.500;C06.552.380.705.422
00000000|MMI|22.06|Diuretics|C0012798|[phsu]|["Diuretic"-tx-20-"diuretic"-adj-0]|TX|[5030/8],[5146/8]|D27.505.696.560.500
00000000|MMI|20.67|day|C0439228|[tmco]|["DAY"-tx-45-"day"-noun-0,"DAYS"-tx-44-"days"-noun-0,"DAYS"-tx-32-"days"-noun-0,"DAY"-tx-21-"day"-noun-0,"DAY"-tx-20-"day"-noun-0,"DAYS"-tx-20-"days"-noun-0,"DAY"-tx-12-"day"-noun-0,"DAYS"-tx-9-"days"-noun-0]|TX|7471/3;7358/4;6107/4;5200/3;5107/3;4971/4;4185/3;3921/4|
00000000|MMI|20.56|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-7-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|3078/7;[857/7],[922/7]|H02.403.044
00000000|MMI|20.51|Diet therapy|C0012159|[hlca]|["Diet"-tx-5-"DIET"-noun-0]|TX|[2804/4],[2838/4],[2906/4]|E02.642.249
00000000|MMI|20.07|Costa Rica|C0010182|[geoa]|["CRI"-tx-18-"CRI"-noun-0,"CRI"-tx-7-"CRI"-noun-0]|TX|4546/3;3710/3|Z01.107.169.238
00000000|MMI|20.07|Urinary tract infection|C0042029|[dsyn]|["URINARY TRACT INFECTION"-tx-7-"urinary tract infection"-noun-0]|TX|[3457/23],[3483/23]|C01.539.895;C12.777.892;C13.351.968.892
00000000|MMI|18.77|Feces|C0015733|[bdsu]|["STOOL"-tx-51-"stool"-noun-0,"Stools"-tx-51-"stools"-noun-0,"Stools"-tx-49-"stools"-noun-0,"STOOL"-tx-29-"stool"-noun-0]|TX|8405/5;8542/6;8086/6;5915/5|A12.459
00000000|MMI|18.63|Heme|C0018966|[bacs,orch]|["Haem"-tx-28-"HEME"-noun-0]|TX|5822/4|D03.383.129.578.840.500.640.587;D03.549.909.500.640.587;D04.345.783.500.640.587;D23.767.727.640.587
00000000|MMI|17.95|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-51-"follow-up"-adj-0,"FOLLOW-UP"-tx-49-"follow-up"-adj-0,"FOLLOW-UP"-tx-48-"follow-up"-adj-0,"FOLLOW-UP"-tx-43-"follow-up"-adj-0,"FOLLOW-UP"-tx-31-"follow-up"-adj-0,"FOLLOW-UP"-tx-5-"FOLLOW UP"-adj-0]|TX|[8310/9],[8380/9];8024/9;7832/9;7322/9;6056/9;2960/9|
00000000|MMI|17.95|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-51-"follow-up"-adj-0,"Follow-Up"-tx-49-"follow-up"-adj-0,"Follow-Up"-tx-48-"follow-up"-adj-0,"Follow-Up"-tx-43-"follow-up"-adj-0,"Follow-Up"-tx-31-"follow-up"-adj-0,"Follow-Up"-tx-5-"FOLLOW UP"-adj-0]|TX|[8310/9],[8380/9];8024/9;7832/9;7322/9;6056/9;2960/9|
00000000|MMI|17.95|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-51-"follow-up"-adj-0,"Follow-up"-tx-49-"follow-up"-adj-0,"Follow-up"-tx-48-"follow-up"-adj-0,"Follow-up"-tx-43-"follow-up"-adj-0,"Follow-up"-tx-31-"follow-up"-adj-0,"Follow-up"-tx-5-"FOLLOW UP"-adj-0]|TX|[8310/9],[8380/9];8024/9;7832/9;7322/9;6056/9;2960/9|
00000000|MMI|17.95|follow-up|C1522577|[hlca]|["Follow Up"-tx-51-"follow-up"-adj-0,"Follow Up"-tx-49-"follow-up"-adj-0,"Follow Up"-tx-48-"follow-up"-adj-0,"Follow Up"-tx-43-"follow-up"-adj-0,"Follow Up"-tx-31-"follow-up"-adj-0,"Follow Up"-tx-5-"FOLLOW UP"-adj-0]|TX|[8310/9],[8380/9];8024/9;7832/9;7322/9;6056/9;2960/9|
00000000|MMI|17.90|Etiology|C1314792|[ftcn]|["Etiology"-tx-40-"etiology"-noun-0,"Etiology"-tx-19-"Etiology"-noun-0]|TX|6993/8;4642/8|N05.715.350.200;N06.850.490.625
00000000|MMI|17.89|Solomon Islands|C0037623|[geoa]|["BP"-tx-23-"BP's"-noun-0,"BP"-tx-13-"BP"-noun-0]|TX|5430/4;4269/2|Z01.639.760.590
00000000|MMI|17.88|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-7-"diabetes mellitus"-noun-0,"Diabetes"-tx-5-"diabetes"-noun-0]|TX|3393/17;2626/8|C18.452.394.750;C19.246
00000000|MMI|17.69|PO-2|C0297199|[orch]|["PO-2"-tx-5-"2 PO"-noun-0,"PO-2"-tx-5-"PO 2"-noun-0]|TX|2667/4;2319/2,2348/1|x.x.x.x
00000000|MMI|17.68|torsemide|C0076840|[orch,phsu]|["TORSEMIDE"-tx-20-"Torsemide"-noun-0,"TORSEMIDE"-tx-5-"TORSEMIDE"-noun-0]|TX|4946/9;1466/9|x.x.x.x
00000000|MMI|17.67|dioctadecylamidospermine|C0640640|[orch]|["1-DOS"-tx-5-"1 Doses"-noun-0]|TX|[1517/1,1541/5],[1699/1,1723/5]|x.x.x.x
00000000|MMI|17.59|Weight decreased|C1262477|[fndg]|["WEIGHTLOSS"-tx-8-"weight loss"-noun-0]|TX|3854/11|C23.888.144.243.963;G07.700.320.249.314.120.200.963
00000000|MMI|17.56|Rheumatoid Factor|C0035448|[aapp,imft]|["RF"-tx-12-"RF"-noun-0]|TX|4256/2|D12.776.124.486.485.114.323.732;D12.776.124.790.651.114.323.732;D12.776.377.715.548.114.323.732
00000000|MMI|17.53|Tamoxifen|C0039286|[orch,phsu]|["TAMOXIFEN"-tx-42-"tamoxifen"-noun-0]|TX|7154/9|D02.455.426.559.389.150.700.900
00000000|MMI|17.45|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-5-"SIMVASTATIN"-noun-0]|TX|1330/11|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|16.48|Hydroxymethylglutaryl-CoA Reductase Inhibitors|C0360714|[orch,phsu]|["Statin"-tx-41-"statin"-noun-0]|TX|7095/6|D27.505.519.186.071.202.370;D27.505.519.389.370;D27.505.954.557.500.202.370
00000000|MMI|16.48|Penicillins|C0030842|[antb,orch]|["PENICILLINS"-tx-7-"Penicillins"-noun-0]|TX|3087/11|D02.065.589.099.750;D02.886.108.750;D03.438.260.825;D03.605.084.737;D04.075.080.875.099.221.750
00000000|MMI|16.48|Surgical aspects|C0038895|[ftcn]|["operations"-tx-7-"OPERATIONS"-noun-0]|TX|3509/10|x.x.x.x.x.x.x
00000000|MMI|16.48|Vitamin B 12|C0042845|[orch,phsu,vita]|["CYANOCOBALAMIN"-tx-5-"CYANOCOBALAMIN"-noun-0]|TX|2474/14|D03.383.129.578.840.437.777;D03.549.909.437.777;D04.345.783.437.777
00000000|MMI|16.48|Walking (activity)|C0080331|[dora]|["Walk"-tx-10-"walk"-verb-0]|TX|4058/4|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|15.98|Doctor - Title|C2348314|[cnce]|["Doctor"-tx-50-"doctor"-noun-0,"Dr."-tx-49-"Dr"-noun-0,"Dr."-tx-43-"Dr"-noun-0,"Dr."-tx-31-"Dr"-noun-0,"Dr."-tx-6-"Dr"-noun-0,"Dr."-tx-5-"Dr"-noun-0]|TX|8246/6;8098/2;7342/2;6087/2;3038/2;2988/2|
00000000|MMI|15.82|Atrial Fibrillation by ECG Finding|C0344434|[lbtr]|["AFib"-tx-19-"afib"-noun-1,"AFib"-tx-18-"AFib"-noun-0,"AF"-tx-14-"AF"-noun-1,"AFib"-tx-7-"AFib"-noun-0,"Atrial Fibrillation"-tx-7-"atrial fibrillation"-noun-0]|TX|4716/4;4529/4;4313/2;3698/4;[3413/19],[3435/19]|
00000000|MMI|15.73|Negation|C1518422|[ftcn]|["Not"-tx-39-"not"-adv-0,"Not"-tx-25-"not"-adv-0,"Not"-tx-23-"not"-adv-0,"Not"-tx-10-"not"-adv-0,"Not"-tx-7-"NOT"-adv-0]|TX|[6888/3],[6950/3];5564/3;5399/3;4054/3;3571/3|
00000000|MMI|15.45|Receptors, Complement 3d|C0056184|[aapp,imft,rcpt]|["CR2"-tx-15-"Cr 2"-noun-0]|TX|4388/2,4392/1|D12.776.543.750.705.833.610;D12.776.543.750.925.250;D23.050.301.264.035.610;D23.101.100.110.610
00000000|MMI|15.43|Advair Diskus|C0939246|[orch,phsu]|["Advair Diskus"-tx-5-"ADVAIR DISKUS"-noun-0]|TX|1758/13|D02.033.100.291.057.750.500;D02.092.063.291.057.750.500;D02.092.471.683.061.750.500;D04.808.054.079.129.114.500;D26.310.438
00000000|MMI|15.40|Insulin, Lente|C0021659|[aapp,horm,phsu]|["Insulin, Lente"-tx-3-"LENTE INSULIN"-noun-0]|TX|587/13|D06.472.699.587.200.300.300;D12.644.548.586.200.300.300
00000000|MMI|15.37|Advair|C0965130|[orch,phsu]|["Advair"-tx-26-"Advair"-noun-0]|TX|5633/6|D02.033.100.291.057.750.500;D02.092.063.291.057.750.500;D02.092.471.683.061.750.500;D04.808.054.079.129.114.500;D26.310.438
00000000|MMI|15.36|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-25-"coumadin"-noun-0]|TX|5571/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|15.32|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-51-"medications"-noun-0,"Medications"-tx-49-"medications"-noun-0,"Medication"-tx-42-"medication"-adj-0,"Medications"-tx-38-"medications"-noun-0,"Medications"-tx-19-"medications"-noun-0,"Medications"-tx-3-"MEDICATIONS"-noun-0]|TX|8441/11;7937/11;7290/10;6776/11;4822/11;465/11|D26
00000000|MMI|15.31|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-7-"Treatment"-noun-0]|TX|3340/9|x.x.x.x.x.x.x
00000000|MMI|15.29|Oxycodone|C0030049|[orch,phsu]|["OXYCODONE"-tx-3-"OXYCODONE"-noun-0]|TX|738/9|D03.132.577.249.562.149.575;D03.549.686.607.204.650;D03.605.497.607.204.650;D04.615.723.795.576.149.575
00000000|MMI|15.28|Order (action)|C1705178|[acty]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|8729/6;[1906/5],[2134/5];1235/5;321/5;175/6|
00000000|MMI|15.28|Order (arrangement)|C1705176|[qlco]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|8729/6;[1906/5],[2134/5];1235/5;321/5;175/6|
00000000|MMI|15.28|Order (document)|C1705175|[inpr]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|8729/6;[1906/5],[2134/5];1235/5;321/5;175/6|
00000000|MMI|15.28|Order (taxonomic)|C1705177|[clas]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|8729/6;[1906/5],[2134/5];1235/5;321/5;175/6|
00000000|MMI|15.28|Permutation|C1882348|[qlco]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|8729/6;[1906/5],[2134/5];1235/5;321/5;175/6|
00000000|MMI|15.28|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-53-"ORDERS"-verb-0,"ORDER"-tx-5-"order"-noun-0,"ORDER"-tx-4-"order"-noun-0,"ORDER"-tx-2-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|8729/6;[1906/5],[2134/5];1235/5;321/5;175/6|
00000000|MMI|15.28|Levaquin|C0721336|[orch,phsu]|["Levaquin"-tx-5-"LEVAQUIN"-noun-0]|TX|1916/8|D03.438.810.835.322.500.500
00000000|MMI|14.76|+2|C0740116|[qnco]|["+2"-tx-35-"2"-fraction-0,"+2"-tx-30-"2"-fraction-0,"+2"-tx-5-"2"-integer-0,"+2"-tx-1-"2"-fraction-0]|TX|6506/1;6015/1;[2562/1],[2829/1],[2912/1];149/1|
00000000|MMI|14.76|2+|C3833492|[fndg]|["2+"-tx-35-"2"-fraction-0,"2+"-tx-30-"2"-fraction-0,"2+"-tx-5-"2"-integer-0,"2+"-tx-1-"2"-fraction-0]|TX|6506/1;6015/1;[2562/1],[2829/1],[2912/1];149/1|
00000000|MMI|14.76|2+ Score|C2827735|[qnco]|["2+"-tx-35-"2"-fraction-0,"2+"-tx-30-"2"-fraction-0,"2+"-tx-5-"2"-integer-0,"2+"-tx-1-"2"-fraction-0]|TX|6506/1;6015/1;[2562/1],[2829/1],[2912/1];149/1|
00000000|MMI|14.76|2+ Score, WHO|C2981700|[clas]|["2+"-tx-35-"2"-fraction-0,"2+"-tx-30-"2"-fraction-0,"2+"-tx-5-"2"-integer-0,"2+"-tx-1-"2"-fraction-0]|TX|6506/1;6015/1;[2562/1],[2829/1],[2912/1];149/1|
00000000|MMI|14.73|Emotions|C0013987|[menp]|["feel"-tx-40-"felt"-verb-0,"feel"-tx-39-"felt"-verb-1,"feel"-tx-33-"felt"-verb-0]|TX|7006/4;6933/4;6353/4|F01.470
00000000|MMI|14.65|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-5-"MG"-noun-0,"Mg+2"-tx-5-"MG 2"-noun-0,"Mg++"-tx-4-"MG"-noun-0,"Mg++"-tx-3-"MG"-noun-0]|TX|2316/2;2316/2,2348/1;1042/2;[514/2],[578/2],[728/2]|
00000000|MMI|14.36|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-52-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-3-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|8678/3;1898/3;843/3;397/3|
00000000|MMI|14.36|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-47-"DM"-noun-0,"DM"-tx-18-"DM"-noun-0,"DM"-tx-7-"DM"-noun-0,"DM"-tx-7-"dm"-noun-0]|TX|7602/2;4541/2;3705/2;3388/2|
00000000|MMI|14.36|Requirement|C1514873|[ftcn]|["Required"-tx-45-"required"-verb-0,"Required"-tx-5-"Required"-verb-0]|TX|7433/8;[1547/8],[1646/8],[1729/8]|
00000000|MMI|14.32|Pyridoxine Hydrochloride|C0700496|[orch,phsu,vita]|["PYRIDOXINE HCL"-tx-4-"PYRIDOXINE HCL"-noun-0]|TX|1022/14|D03.383.725.676.925.875
00000000|MMI|14.13|Infection|C3714514|[patf]|["INFECTION"-tx-38-"infection"-noun-1,"INFECTION"-tx-19-"infection"-noun-1,"Infections"-tx-7-"Infections"-noun-0]|TX|6763/9;4737/9;3301/10|C01.539
00000000|MMI|14.05|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-7-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|3078/7;[857/7],[922/7]|C20.543
00000000|MMI|13.83|Disease|C0012634|[dsyn]|["condition"-tx-51-"CONDITION"-noun-0,"condition"-tx-7-"Conditions"-noun-0]|TX|8277/9;3288/10|C23.550.288
00000000|MMI|13.58|Etiology aspects|C0015127|[ftcn]|["etiology"-tx-40-"etiology"-noun-0,"etiology"-tx-19-"Etiology"-noun-0]|TX|6993/8;4642/8|x.x.x
00000000|MMI|13.58|Communicable Diseases|C0009450|[dsyn]|["Infection, NOS"-tx-38-"infection"-noun-1,"Infection, NOS"-tx-19-"infection"-noun-1]|TX|6763/9;4737/9|C01.539.221
00000000|MMI|13.55|Hepatitis|C0019158|[dsyn]|["HEPATITIS"-tx-51-"hepatitis"-noun-0,"HEPATITIS"-tx-38-"hepatitis"-noun-1]|TX|8340/9;6790/9|C06.552.380
00000000|MMI|13.26|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-49-"Dr"-noun-0,"DR"-tx-43-"Dr"-noun-0,"DR"-tx-31-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|8098/2;7342/2;6087/2;3038/2;2988/2|
00000000|MMI|13.26|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-49-"Dr"-noun-0,"DR"-tx-43-"Dr"-noun-0,"DR"-tx-31-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|8098/2;7342/2;6087/2;3038/2;2988/2|
00000000|MMI|13.22|Adherence To Medication Regime|C2364172|[fndg]|["Medication compliance"-tx-11-"compliant medications"-noun-0]|TX|4116/9,4135/11|F01.145.488.500.500;N05.300.150.600.600.500
00000000|MMI|13.22|Medication Compliance|C3489773|[inbe]|["Medication Compliance"-tx-11-"compliant medications"-noun-0]|TX|4116/9,4135/11|F01.145.488.500.500;N05.300.150.600.600.500
00000000|MMI|13.20|District of Columbia|C0012764|[geoa]|["D.C."-tx-2-"D/C"-noun-0]|TX|317/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|13.17|Diastole|C0012000|[clna]|["Diastolic"-tx-7-"diastolic"-adj-0]|TX|3663/9|G09.330.190.541.295;G11.427.590.540.554.250;G11.427.590.540.570.295
00000000|MMI|13.16|Nexium|C0939400|[orch,phsu]|["Nexium"-tx-36-"Nexium"-noun-0]|TX|6585/6|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|13.16|fluticasone|C0082607|[orch,phsu]|["FLUTICASONE"-tx-5-"FLUTICASONE"-noun-0]|TX|1586/11|D04.808.054.079.129.114
00000000|MMI|13.14|Sleep Apnea, Obstructive|C0520679|[dsyn]|["OSA"-tx-7-"OSA"-noun-0]|TX|3716/3|C08.618.085.852.850;C10.886.425.800.750.850
00000000|MMI|12.92|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-48-"scheduled"-adj-0,"Scheduled"-tx-43-"scheduled"-verb-0,"Scheduled"-tx-31-"scheduled"-verb-0,"Scheduled"-tx-7-"scheduled"-adj-0,"Scheduled"-tx-6-"scheduled"-verb-0]|TX|7817/9;7309/9;6043/9;3066/9;3026/9|
00000000|MMI|12.92|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-48-"scheduled"-adj-0,"Scheduled"-tx-43-"scheduled"-verb-0,"Scheduled"-tx-31-"scheduled"-verb-0,"Scheduled"-tx-7-"scheduled"-adj-0,"Scheduled"-tx-6-"scheduled"-verb-0]|TX|7817/9;7309/9;6043/9;3066/9;3026/9|
00000000|MMI|12.92|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-48-"scheduled"-adj-0,"Scheduled"-tx-43-"scheduled"-verb-0,"Scheduled"-tx-31-"scheduled"-verb-0,"Scheduled"-tx-7-"scheduled"-adj-0,"Scheduled"-tx-6-"scheduled"-verb-0]|TX|7817/9;7309/9;6043/9;3066/9;3026/9|
00000000|MMI|12.59|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-51-"medications"-noun-0,"Medications"-tx-49-"medications"-noun-0,"Medications"-tx-38-"medications"-noun-0,"Medications"-tx-19-"medications"-noun-0,"Medications"-tx-3-"MEDICATIONS"-noun-0]|TX|8441/11;7937/11;6776/11;4822/11;465/11|
00000000|MMI|12.59|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-51-"medications"-noun-0,"Medications"-tx-49-"medications"-noun-0,"Medications"-tx-38-"medications"-noun-0,"Medications"-tx-19-"medications"-noun-0,"Medications"-tx-3-"MEDICATIONS"-noun-0]|TX|8441/11;7937/11;6776/11;4822/11;465/11|
00000000|MMI|12.43|Additional|C1524062|[ftcn]|["Added"-tx-47-"added"-verb-0,"Added"-tx-5-"added"-verb-0,"Added"-tx-4-"added"-verb-0,"Added"-tx-3-"added"-verb-0]|TX|7705/5;[1851/5],[2090/5];1191/5;796/5|
00000000|MMI|12.40|Concern|C2699424|[idcn]|["Concern"-tx-51-"concern"-noun-0,"Concern"-tx-50-"concerning"-adj-0,"Concern"-tx-47-"concern"-noun-0,"Concern"-tx-32-"concerning"-noun-0,"Concern"-tx-30-"concern"-noun-0]|TX|8494/7;8207/10;7644/7;6193/10;6019/7|
00000000|MMI|12.28|Home environment|C0442519|[cnce]|["HOME"-tx-47-"home"-noun-0,"HOME"-tx-27-"home"-adj-0,"HOME"-tx-20-"home"-noun-0,"house"-tx-5-"House"-noun-0]|TX|7677/4;5773/4;5025/4;[2844/5],[2881/5]|
00000000|MMI|12.19|Drop - Unit of Volume|C4048603|[qnco]|["Drop"-tx-51-"drop"-noun-0,"Drop"-tx-32-"drop"-noun-0,"Drop"-tx-5-"DROP"-noun-0,"Drop"-tx-3-"DROP"-noun-0]|TX|8419/4;6157/4;[1519/4],[1701/4];553/4|
00000000|MMI|12.19|Drop British|C2348338|[qnco]|["Drop"-tx-51-"drop"-noun-0,"Drop"-tx-32-"drop"-noun-0,"Drop"-tx-5-"DROP"-noun-0,"Drop"-tx-3-"DROP"-noun-0]|TX|8419/4;6157/4;[1519/4],[1701/4];553/4|
00000000|MMI|12.19|Drop measurement|C1321095|[qnco]|["Drop"-tx-51-"drop"-noun-0,"Drop"-tx-32-"drop"-noun-0,"Drop"-tx-5-"DROP"-noun-0,"Drop"-tx-3-"DROP"-noun-0]|TX|8419/4;6157/4;[1519/4],[1701/4];553/4|
00000000|MMI|12.19|Dropping|C1705648|[acty]|["Drop"-tx-51-"drop"-noun-0,"Drop"-tx-32-"drop"-noun-0,"Drop"-tx-5-"DROP"-noun-0,"Drop"-tx-3-"DROP"-noun-0]|TX|8419/4;6157/4;[1519/4],[1701/4];553/4|
00000000|MMI|12.19|Medical Drop|C2347093|[qnco]|["Drop"-tx-51-"drop"-noun-0,"Drop"-tx-32-"drop"-noun-0,"Drop"-tx-5-"DROP"-noun-0,"Drop"-tx-3-"DROP"-noun-0]|TX|8419/4;6157/4;[1519/4],[1701/4];553/4|
00000000|MMI|12.17|Atypical Lipoma|C1266129|[neop]|["ALT"-tx-37-"ALT"-noun-0]|TX|6674/3|C04.557.450.550.400
00000000|MMI|12.17|Demerol|C0935966|[orch,phsu]|["Demerol"-tx-7-"Demerol"-noun-0]|TX|3101/7|D03.066.399.450;D03.383.621.349.450
00000000|MMI|12.17|Diabetic Diet|C0011878|[topp]|["Diabetic Diet"-tx-46-"diabetic diet"-noun-0]|TX|7576/13|E02.642.249.240;G07.203.650.240.240
00000000|MMI|12.17|Dichlorodiphenyl Dichloroethylene|C0011038|[hops,orch]|["DDX"-tx-38-"DDX"-noun-0]|TX|6736/3|D02.455.526.439.292
00000000|MMI|12.17|Kidney Failure|C0035078|[dsyn]|["Failure, Renal"-tx-18-"renal failure"-noun-0]|TX|4626/13|C12.777.419.780;C13.351.968.419.780
00000000|MMI|12.17|Levothyroxine Sodium|C0079691|[aapp,horm,phsu]|["Laevothyroxine sodium"-tx-3-"LEVOTHYROXINE SODIUM"-noun-0]|TX|664/20|D06.472.931.812;D12.125.072.050.767
00000000|MMI|12.17|Macrodantin|C0700187|[orch,phsu]|["Macrodantin"-tx-7-"Macrodantin"-noun-0]|TX|3111/11|D02.640.600.566;D03.383.312.649.566
00000000|MMI|12.17|Metolazone|C0025854|[orch,phsu]|["METOLAZONE"-tx-3-"METOLAZONE"-noun-0]|TX|713/10|D02.065.884.600;D02.886.590.700.600;D03.438.786.830.688
00000000|MMI|12.17|Niacin|C0027996|[phsu,vita]|["NIACIN"-tx-4-"NIACIN"-noun-0]|TX|1306/6|D03.066.515.475;D03.383.725.547.475
00000000|MMI|12.17|Nitrofurantoin|C0028156|[orch,phsu]|["NITROFURANTOIN"-tx-7-"nitrofurantoin"-noun-0]|TX|3125/14|D02.640.600.566;D03.383.312.649.566
00000000|MMI|12.17|Omeprazole|C0028978|[orch,phsu]|["OMEPRAZOLE"-tx-5-"OMEPRAZOLE"-noun-0]|TX|2300/10|D02.886.640.074.500;D03.383.725.024.500;D03.438.103.034.500
00000000|MMI|12.17|Patient Non-Compliance|C0376405|[fndg]|["MEDICAL NONCOMPLIANCE"-tx-19-"medical non-compliance"-noun-1]|TX|4789/22|F01.145.488.500;N05.300.150.600.600
00000000|MMI|12.08|Unit|C0439148|[qnco]|["UNITS"-tx-5-"UNITS"-noun-0,"UNITS"-tx-4-"UNITS"-noun-0,"UNITS"-tx-3-"UNITS"-noun-0]|TX|[1414/5],[2433/5],[2567/5];1089/5;639/5|
00000000|MMI|12.08|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Units"-tx-5-"UNITS"-noun-0,"Units"-tx-4-"UNITS"-noun-0,"Units"-tx-3-"UNITS"-noun-0]|TX|[1414/5],[2433/5],[2567/5];1089/5;639/5|
00000000|MMI|12.08|Unit of Measure|C1519795|[qnco]|["Units"-tx-5-"UNITS"-noun-0,"Units"-tx-4-"UNITS"-noun-0,"Units"-tx-3-"UNITS"-noun-0]|TX|[1414/5],[2433/5],[2567/5];1089/5;639/5|
00000000|MMI|12.06|Milligram percent|C1960952|[qnco]|["mg %"-tx-5-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0,"mg %"-tx-3-"MG"-noun-0]|TX|2316/2;1042/2;[514/2],[578/2],[728/2]|
00000000|MMI|12.06|mg/dL|C0439269|[qnco]|["mg%"-tx-5-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0,"mg%"-tx-3-"MG"-noun-0]|TX|2316/2;1042/2;[514/2],[578/2],[728/2]|
00000000|MMI|11.17|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-5-"Low fat DIET"-noun-0]|TX|2852/3,2871/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|11.17|Vitamin B6|C0087162|[orch,phsu,vita]|["Vitamin B 6"-tx-4-"VITAMIN B 6"-noun-0]|TX|1008/11|D03.383.725.676.925
00000000|MMI|11.14|Fluorides|C0016327|[inch,phsu]|["F-"-tx-48-"f"-noun-0]|TX|7827/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|11.14|In Blood|C0005768|[bdsu]|["BLOOD"-tx-32-"blood"-noun-0]|TX|6282/5|x.x.x.x.x
00000000|MMI|11.14|Prilosec|C0700777|[orch,phsu]|["PriLOSEC"-tx-5-"PRILOSEC"-noun-0]|TX|2289/8|D02.886.640.074.500;D03.383.725.024.500;D03.438.103.034.500
00000000|MMI|11.14|Sodium Chloride|C0037494|[bacs,inch,phsu]|["Salt"-tx-22-"salt"-noun-0]|TX|5356/4|D01.210.450.150.875;D01.857.650
00000000|MMI|11.11|Vitamin E|C0042874|[orch,phsu,vita]|["VITAMIN E"-tx-4-"VITAMIN E"-noun-0]|TX|1051/9|D03.383.663.283.909;D03.438.150.909
00000000|MMI|11.09|Synthroid|C0728762|[aapp,phsu]|["Synthroid"-tx-3-"SYNTHROID"-noun-0]|TX|652/9|D06.472.931.812;D12.125.072.050.767
00000000|MMI|11.09|Zaroxolyn|C0701383|[orch,phsu]|["Zaroxolyn"-tx-3-"ZAROXOLYN"-noun-0]|TX|701/9|D02.065.884.600;D02.886.590.700.600;D03.438.786.830.688
00000000|MMI|11.08|Sudden infant death syndrome|C0038644|[dsyn]|["SID"-tx-32-"Sid"-noun-0]|TX|6091/3|C23.550.260.322.625;C23.550.260.657.500
00000000|MMI|11.02|Potassium Chloride|C0032825|[inch,phsu]|["POTASSIUM CHLORIDE"-tx-5-"Potassium Chloride"-noun-0]|TX|2687/18|D01.210.450.150.750;D01.745.625
00000000|MMI|11.02|Respiratory rate|C0231832|[clna]|["RESP"-tx-15-"resp"-noun-0]|TX|4409/4|E01.370.600.875.875;G09.772.770.755.730
00000000|MMI|11.00|Iodides|C0021966|[inch]|["I-"-tx-22-"I"-noun-0]|TX|5323/1|D01.248.497.158.490;D01.475.410
00000000|MMI|10.99|Lebanon|C0023190|[geoa]|["LE"-tx-17-"LE"-noun-0]|TX|4487/2|Z01.252.245.500.450
00000000|MMI|10.99|Folic Acid|C0016410|[orch,phsu,vita]|["FOLIC ACID"-tx-3-"FOLIC ACID"-noun-0]|TX|565/10|D03.438.733.631.400
00000000|MMI|10.98|Pain|C0030193|[sosy]|["PAIN"-tx-3-"Pain"-noun-0]|TX|764/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|10.98|Albuterol|C0001927|[orch,phsu]|["ALBUTEROL"-tx-5-"ALBUTEROL"-noun-0]|TX|2326/9|D02.033.100.291.057;D02.092.063.291.057;D02.092.471.683.061
00000000|MMI|10.97|Diuretic Effect|C0948429|[fndg]|["Diuretic Effect"-tx-20-"diuretic effect"-noun-0]|TX|5146/15|D27.505.696.560.500
00000000|MMI|10.97|Saint Lucia|C0036056|[geoa]|["ST"-tx-14-"ST"-adj-0]|TX|4324/2|Z01.107.084.900.825;Z01.639.880.825
00000000|MMI|10.96|Ivory Coast|C0022326|[geoa]|["IV"-tx-20-"IV"-noun-0]|TX|4960/2|Z01.058.290.190.272
00000000|MMI|10.96|Community|C0009462|[geoa]|["Community"-tx-5-"community"-noun-0]|TX|2607/9|N01.224.791;N06.850.505.400.800
00000000|MMI|10.70|Approximate|C0332232|[qlco]|["Approximate"-tx-5-"approximate"-adj-0]|TX|[1558/11],[1657/11],[1740/11]|
00000000|MMI|10.70|Fatigue Subordinate Domain|C4050243|[inpr]|["Fatigue"-tx-50-"fatigue"-noun-0,"Fatigue"-tx-9-"fatigue"-noun-0,"Fatigue"-tx-7-"fatigue"-noun-0]|TX|8163/7;3970/7;3746/7|
00000000|MMI|10.70|Including (qualifier)|C0332257|[ftcn]|["included"-tx-42-"included"-verb-0,"included"-tx-38-"included"-verb-0,"Including"-tx-7-"including"-verb-0]|TX|7233/8;6740/8;3647/9|
00000000|MMI|10.70|Percocet|C0086787|[orch,phsu]|["Percocet"-tx-51-"percocet"-noun-0,"Percocet"-tx-49-"percocet"-noun-0,"Percocet"-tx-41-"percocet"-noun-0]|TX|8560/8;7960/8;7104/8|
00000000|MMI|10.56|Then|C1883708|[tmco]|["Next"-tx-32-"next"-adj-0,"Then"-tx-28-"then"-adv-0,"Then"-tx-20-"then"-adv-0,"Then"-tx-9-"then"-adv-0]|TX|6277/4;5878/4;5004/4;3928/4|
00000000|MMI|10.01|Endometriosis|C0014175|[dsyn]|["Endo"-tx-47-"ENDO"-adj-0]|TX|7594/4|C13.351.500.163
00000000|MMI|10.01|Thrombocytopenia|C0040034|[fndg]|["thrombocytopaenia"-tx-32-"THROMBOCYTOPENIA"-noun-0]|TX|6131/16|C15.378.140.855
00000000|MMI|10.01|gabapentin|C0060926|[orch,phsu]|["GABAPENTIN"-tx-5-"GABAPENTIN"-noun-0]|TX|1439/10|x.x.x.x
00000000|MMI|10.01|latanoprost|C0090306|[orch,phsu]|["LATANOPROST"-tx-5-"LATANOPROST"-noun-0]|TX|1685/11|x.x.x.x
00000000|MMI|10.01|phosphoethanolamine|C0070939|[bacs,orch]|["PE"-tx-15-"PE"-noun-0]|TX|4398/2|x.x.x.x
00000000|MMI|9.95|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-5-"Reason"-noun-0,"Reason"-tx-4-"Reason"-noun-0]|TX|[1342/6],[2020/6],[2252/6];978/6|
00000000|MMI|9.90|30%|C3842588|[fndg]|["30%"-tx-28-"30"-real_number-0,"30%"-tx-15-"30"-real_number-0,"30%"-tx-5-"30"-fraction-0,"30%"-tx-5-"30"-integer-0]|TX|5865/2;4353/2;[1396/2],[1573/2];[1396/2],[1573/2]|
00000000|MMI|9.90|per day|C0439505|[tmco]|["/day"-tx-45-"day"-noun-0,"/day"-tx-21-"day"-noun-0,"/day"-tx-20-"day"-noun-0,"/day"-tx-12-"day"-noun-0]|TX|7471/3;5200/3;5107/3;4185/3|
00000000|MMI|9.90|Medical History|C0262926|[fndg]|["Hx"-tx-25-"hx"-noun-1,"Hx"-tx-19-"hx"-noun-1,"Hx"-tx-18-"hx"-noun-0,"PMH"-tx-7-"PMHs"-noun-0]|TX|5586/2;4752/2;4554/2;3642/4|
00000000|MMI|9.90|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-5-"dose"-noun-0,"Dose number"-tx-5-"Number Doses"-noun-0]|TX|2726/4;[1531/6,1541/5],[1630/6,1640/5],[1713/6,1723/5]|
00000000|MMI|9.89|Following|C0332282|[tmco]|["Following"-tx-51-"following"-adj-0,"Following"-tx-49-"following"-adj-0,"Following"-tx-44-"following"-verb-0,"Next"-tx-32-"next"-adj-0]|TX|8431/9;7927/9;7363/9;6277/4|
00000000|MMI|9.79|Place|C0442504|[spco]|["Place"-tx-47-"placed"-verb-0,"Place"-tx-46-"placed"-verb-0,"Place"-tx-36-"placed"-verb-0,"Place"-tx-27-"placed"-verb-0]|TX|7623/6;7552/6;6530/6;5676/6|
00000000|MMI|9.79|Place - dosing instruction imperative|C1704765|[ftcn]|["Place"-tx-47-"placed"-verb-0,"Place"-tx-46-"placed"-verb-0,"Place"-tx-36-"placed"-verb-0,"Place"-tx-27-"placed"-verb-0]|TX|7623/6;7552/6;6530/6;5676/6|
00000000|MMI|9.79|put - instruction imperative|C1882509|[acty]|["Place"-tx-47-"placed"-verb-0,"Place"-tx-46-"placed"-verb-0,"Place"-tx-36-"placed"-verb-0,"Place"-tx-27-"placed"-verb-0]|TX|7623/6;7552/6;6530/6;5676/6|
00000000|MMI|9.69|Good|C0205170|[qlco]|["Well"-tx-27-"well"-adv-0,"Good"-tx-24-"good"-adj-0,"Good"-tx-20-"good"-adj-0,"Well"-tx-9-"well"-adv-0]|TX|5707/4;5487/4;5141/4;3906/4|
00000000|MMI|9.69|Digestive System Findings Domain|C3539617|[inpr]|["GI"-tx-43-"GI"-noun-0,"GI"-tx-36-"GI"-noun-0,"GI"-tx-31-"GI"-noun-0,"GI"-tx-25-"GI"-noun-0]|TX|7337/2;6595/2;6075/2;5592/2|
00000000|MMI|9.69|GNAI1 wt Allele|C1708130|[gngm]|["Gi"-tx-43-"GI"-noun-0,"Gi"-tx-36-"GI"-noun-0,"Gi"-tx-31-"GI"-noun-0,"Gi"-tx-25-"GI"-noun-0]|TX|7337/2;6595/2;6075/2;5592/2|
00000000|MMI|9.69|Gastrointestinal studies and measurements|C4050121|[inpr]|["GI"-tx-43-"GI"-noun-0,"GI"-tx-36-"GI"-noun-0,"GI"-tx-31-"GI"-noun-0,"GI"-tx-25-"GI"-noun-0]|TX|7337/2;6595/2;6075/2;5592/2|
00000000|MMI|9.63|100%|C3817553|[qnco]|["100%"-tx-20-"100"-integer-0,"100%"-tx-5-"100"-fraction-0,"100%"-tx-5-"100"-integer-0,"100%"-tx-3-"100"-integer-0]|TX|4956/3;[1476/3],[1772/3];[1476/3],[1772/3];635/3|
00000000|MMI|9.58|Every morning|C0585329|[tmco]|["QAM"-tx-5-"QAM"-noun-0,"QAM"-tx-3-"QAM"-noun-0]|TX|[1423/3],[2506/3],[2576/3];734/3|
00000000|MMI|9.05|Home visit (procedure)|C0020043|[hlca]|["home services"-tx-3-"Home services"-noun-0]|TX|438/4,446/8|N04.452.758.307
00000000|MMI|8.98|Rales|C0034642|[sosy]|["RALES"-tx-16-"rales"-noun-0]|TX|4461/5|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|8.98|Sodium Chloride, Dietary|C0206136|[food]|["Salt"-tx-22-"salt"-noun-0]|TX|5356/4|D01.857.650.705;D01.857.700.705
00000000|MMI|8.98|dorzolamide|C0165590|[orch,phsu]|["DORZOLAMIDE"-tx-5-"DORZOLAMIDE"-noun-0]|TX|1500/11|x.x.x.x
00000000|MMI|8.95|Dipivefrin|C0058415|[orch,phsu]|["DIPIVEFRIN"-tx-3-"DIPIVEFRIN"-noun-0]|TX|533/10|x.x.x.x
00000000|MMI|8.94|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-15-"baseline"-noun-0]|TX|4379/8|x.x.x.x
00000000|MMI|8.94|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-51-"PLAN"-noun-0]|TX|8301/4|C10.228.140.744
00000000|MMI|8.93|Methylacetylene|C0066315|[irda,orch]|["Propyne"-tx-3-"PROPINE"-noun-0]|TX|523/7|x.x.x.x
00000000|MMI|8.91|Diuresis|C0012797|[ortf]|["Diuresis"-tx-39-"diuresis"-noun-0]|TX|6915/8|G08.852.796.241
00000000|MMI|8.90|Heparin|C0019134|[bacs,orch,phsu]|["HEPARIN"-tx-36-"Heparin"-noun-0]|TX|6540/7|D09.698.373.400
00000000|MMI|8.90|Nurses|C0028661|[prog]|["NURSE"-tx-48-"nurse"-noun-0]|TX|7868/5|M01.526.485.650;N02.360.650
00000000|MMI|8.89|Foot|C0016504|[bpoc]|["Feet"-tx-10-"feet"-noun-0]|TX|4077/4|A01.378.610.250
00000000|MMI|8.88|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-2-"D/C"-noun-0]|TX|317/3|E04.157.310;E04.950.300.299
00000000|MMI|8.84|Sodium|C0037473|[bacs,elii]|["SODIUM"-tx-5-"Sodium"-noun-0]|TX|2919/6|D01.268.549.750;D01.268.557.650;D01.552.528.850;D01.552.547.725;x.x.x.x
00000000|MMI|8.83|OSA protein, Drosophila|C0764906|[aapp,bacs]|["OSA"-tx-7-"OSA"-noun-0]|TX|3716/3|x.x.x.x
00000000|MMI|8.83|Honduras|C0019905|[geoa]|["HO"-tx-2-"Ho"-noun-0]|TX|223/2|Z01.107.169.534
00000000|MMI|8.82|Facial Hemiatrophy|C0015458|[dsyn]|["HFA"-tx-5-"HFA"-noun-0]|TX|2344/3|C07.465.284;C07.465.299.375;C10.292.319.375
00000000|MMI|8.82|Wheezing|C0043144|[sosy]|["WHEEZING"-tx-5-"Wheezing"-noun-0]|TX|2369/8|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|8.82|Automobiles|C0004381|[mnob]|["Car"-tx-2-"CAR"-noun-0]|TX|235/3|J01.937.500.100
00000000|MMI|8.82|Colombia|C3245499|[geoa]|["CO"-tx-33-"CO"-noun-0]|TX|6387/2|Z01.107.757.284
00000000|MMI|8.82|Panama|C0030266|[geoa]|["PM"-tx-2-"PM"-adj-0]|TX|278/2|Z01.107.169.772
00000000|MMI|8.81|Kyrgyzstan|C0022718|[geoa]|["KG"-tx-21-"kg"-noun-0]|TX|5260/2|Z01.252.100.450;Z01.586.200.450;Z01.586.950.450
00000000|MMI|8.81|Hospitals, Community|C0020003|[hcro,mnob]|["Community hospital"-tx-5-"community hospital"-noun-0]|TX|2607/18|N02.278.421.306
00000000|MMI|7.85|Abdomen|C0000726|[blor]|["abd"-tx-16-"abd"-noun-0]|TX|4469/3|A01.923.047
00000000|MMI|7.85|Complication Aspects|C1171258|[patf]|["complications"-tx-7-"Complications"-noun-0]|TX|3314/13|x.x.x
00000000|MMI|7.85|Drawings (art)|C0013113|[inpr]|["Draw"-tx-32-"draw"-verb-0]|TX|6288/4|V01.185.625;V02.700.300
00000000|MMI|7.85|Hemorrhage|C0019080|[patf]|["bleed"-tx-25-"bleed"-verb-1]|TX|5595/5|C23.550.414
00000000|MMI|7.85|Kidney|C0022646|[bpoc]|["Renal"-tx-33-"RENAL"-adj-0]|TX|6295/5|A05.810.453
00000000|MMI|7.85|Methods aspects|C0025664|[inpr]|["procedures"-tx-7-"PROCEDURES"-noun-0]|TX|3524/10|x.x.x
00000000|MMI|7.82|To be stopped|C1272691|[qlco]|["stopped"-tx-51-"stopped"-verb-0,"stopped"-tx-35-"stopped"-verb-0,"stopped"-tx-30-"stopped"-verb-0]|TX|8458/7;6498/7;6007/7|
00000000|MMI|7.60|ALYREF gene|C1425988|[gngm]|["REF"-tx-5-"ref"-noun-0,"REF"-tx-4-"ref"-noun-0]|TX|[1930/3],[2162/3];1256/3|
00000000|MMI|7.58|CENPJ gene|C1424863|[gngm]|["CPAP"-tx-27-"CPAP"-noun-0,"CPAP"-tx-27-"cpap"-noun-0]|TX|[5686/4],[5765/4];5717/4|
00000000|MMI|7.57|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-7-"Service"-noun-0,"service"-tx-2-"SERVICE"-noun-0,"service"-tx-2-"Service"-noun-0]|TX|3042/7;370/7;226/7|
00000000|MMI|7.57|Services|C0557854|[ocac]|["Service"-tx-7-"Service"-noun-0,"Service"-tx-2-"SERVICE"-noun-0,"Service"-tx-2-"Service"-noun-0]|TX|3042/7;370/7;226/7|
00000000|MMI|7.57|Software Service|C2825316|[mnob]|["Service"-tx-7-"Service"-noun-0,"Service"-tx-2-"SERVICE"-noun-0,"Service"-tx-2-"Service"-noun-0]|TX|3042/7;370/7;226/7|
00000000|MMI|7.53|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-7-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|3078/7;[857/7],[922/7]|
00000000|MMI|7.53|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-7-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|3078/7;[857/7],[922/7]|
00000000|MMI|7.53|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-7-"ALLERGY"-noun-0,"ALLERGY"-tx-4-"ALLERGY"-noun-0]|TX|3078/7;[857/7],[922/7]|
00000000|MMI|7.51|HPX wt Allele|C3814444|[gngm]|["HX"-tx-25-"hx"-noun-0,"HX"-tx-19-"hx"-noun-0,"HX"-tx-18-"hx"-noun-0]|TX|5586/2;4752/2;4554/2|
00000000|MMI|7.50|Interaction|C1704675|[ftcn]|["Interaction"-tx-5-"INTERACTION"-noun-0,"Interaction"-tx-4-"INTERACTION"-noun-0]|TX|[1967/11],[2199/11];1293/11|
00000000|MMI|7.49|0%|C3842591|[fndg]|["0%"-tx-37-"0"-real_number-0,"0%"-tx-15-"0"-integer-0,"0%"-tx-3-"0"-percentage-0]|TX|6730/1;4394/1;544/1|
00000000|MMI|7.48|Basal Diet|C2983588|[food]|["DIET"-tx-5-"DIET"-noun-0]|TX|[2804/4],[2838/4],[2906/4]|
00000000|MMI|7.48|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-5-"DIET"-noun-0]|TX|[2804/4],[2838/4],[2906/4]|
00000000|MMI|7.48|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-5-"DIET"-noun-0]|TX|[2804/4],[2838/4],[2906/4]|
00000000|MMI|7.43|Status post|C0231290|[tmco]|["Following"-tx-51-"following"-adj-0,"Following"-tx-49-"following"-adj-0,"Following"-tx-44-"following"-verb-0]|TX|8431/9;7927/9;7363/9|
00000000|MMI|7.40|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-7-"Treatment"-noun-0,"Therapeutic"-tx-4-"THERAPEUTIC"-adj-0]|TX|3340/9;[1114/11],[1128/11]|E02
00000000|MMI|7.34|Dose number|C1115464|[qnco]|["Dose number"-tx-5-"Number Doses"-noun-0]|TX|[1531/6,1541/5],[1630/6,1640/5],[1713/6,1723/5]|
00000000|MMI|7.32|Count of entities|C0449788|[qnco]|["Number"-tx-5-"Number"-noun-0]|TX|[1531/6],[1630/6],[1713/6]|
00000000|MMI|7.32|Numbers|C0237753|[qnco]|["*Number"-tx-5-"Number"-noun-0]|TX|[1531/6],[1630/6],[1713/6]|
00000000|MMI|7.30|Discharge time|C3864299|[tmco]|["Discharge time"-tx-48-"time discharge"-noun-0,"Discharge time"-tx-38-"time discharge"-noun-0,"Discharge time"-tx-34-"time discharge"-noun-0]|TX|7772/4,7780/9;6847/4,6855/9;6461/4,6469/9|
00000000|MMI|7.30|Discharge time:ClockTime:Pt:^Patient:Qn|C3864300|[clna]|["Discharge time"-tx-48-"time discharge"-noun-0,"Discharge time"-tx-38-"time discharge"-noun-0,"Discharge time"-tx-34-"time discharge"-noun-0]|TX|7772/4,7780/9;6847/4,6855/9;6461/4,6469/9|
00000000|MMI|7.25|Resolution|C2699488|[cnce]|["Resolve"-tx-39-"resolve"-verb-0,"Resolved"-tx-34-"resolved"-verb-0,"Resolution"-tx-32-"resolution"-noun-0]|TX|6892/7;6420/8;6259/10|
00000000|MMI|7.22|50%|C3842586|[fndg]|["50%"-tx-5-"50"-fraction-0,"50%"-tx-5-"50"-integer-0,"50%"-tx-4-"50"-integer-0]|TX|[1776/2],[2564/2];[1776/2],[2564/2];1039/2|
00000000|MMI|7.22|<50|C3843766|[fndg]|["<50"-tx-5-"50"-fraction-0,"<50"-tx-5-"50"-integer-0,"<50"-tx-4-"50"-integer-0]|TX|[1776/2],[2564/2];[1776/2],[2564/2];1039/2|
00000000|MMI|7.21|Elevation|C0702240|[spco]|["elevations"-tx-51-"elevations"-noun-0,"elevations"-tx-49-"elevations"-noun-0,"Elevation"-tx-34-"elevation"-noun-0]|TX|8328/10;8055/10;6400/9|
00000000|MMI|7.19|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-51-"Stable"-adj-0,"Stable"-tx-48-"stable"-adj-0,"Stable"-tx-29-"stable"-adj-0]|TX|8288/6;7762/6;5960/6|
00000000|MMI|7.19|Stable status|C0205360|[qlco]|["STABLE"-tx-51-"Stable"-adj-0,"STABLE"-tx-48-"stable"-adj-0,"STABLE"-tx-29-"stable"-adj-0]|TX|8288/6;7762/6;5960/6|
00000000|MMI|7.18|Serious|C0205404|[qlco]|["Serious"-tx-5-"SERIOUS"-adj-0,"Serious"-tx-4-"SERIOUS"-adj-0]|TX|[1959/7],[2191/7];1285/7|
00000000|MMI|7.17|R prime|C2603358|[clna]|["R'"-tx-19-"r"-adj-0,"R'"-tx-7-"R"-noun-0]|TX|[4683/1],[4871/1];3580/1|
00000000|MMI|7.17|Right|C0205090|[spco]|["R-"-tx-19-"r"-adj-0,"R-"-tx-7-"R"-noun-0]|TX|[4683/1],[4871/1];3580/1|
00000000|MMI|7.12|20%|C3842589|[fndg]|["20%"-tx-5-"20"-integer-0]|TX|[2313/2],[2658/2],[2719/2]|
00000000|MMI|7.10|Antimicrobial susceptibility|C0427965|[fndg]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|[870/11],[935/11]|
00000000|MMI|7.10|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-51-"ASA"-noun-0,"ASA"-tx-30-"ASA"-noun-0]|TX|8613/3;5999/3|
00000000|MMI|7.10|Atrial Fibrillation Adverse Event|C1963067|[fndg]|["Atrial fibrillation"-tx-7-"atrial fibrillation"-noun-0]|TX|[3413/19],[3435/19]|
00000000|MMI|7.10|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-18-"CRI"-noun-0,"CRi"-tx-7-"CRI"-noun-0]|TX|4546/3;3710/3|
00000000|MMI|7.10|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-18-"CRI"-noun-0,"CRI"-tx-7-"CRI"-noun-0]|TX|4546/3;3710/3|
00000000|MMI|7.10|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-7-"DIAGNOSIS"-noun-0]|TX|[3148/9],[3278/9]|E01
00000000|MMI|7.10|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-7-"DIAGNOSIS"-noun-0]|TX|[3148/9],[3278/9]|
00000000|MMI|7.10|Diagnostic Sensitivity|C1511883|[qnco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|[870/11],[935/11]|
00000000|MMI|7.10|Fluid restriction|C0204700|[topp]|["Fluid restriction"-tx-46-"fluid restriction"-noun-0,"Fluid restriction"-tx-5-"Fluid restriction"-noun-0]|TX|7530/17;2810/17|
00000000|MMI|7.10|Increased Sensitivy|C2346484|[phpr]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|[870/11],[935/11]|
00000000|MMI|7.10|Personality Sensitivity|C0312418|[menp]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|[870/11],[935/11]|
00000000|MMI|7.10|RNH1 gene|C1826843|[gngm]|["CRI"-tx-18-"CRI"-noun-0,"CRI"-tx-7-"CRI"-noun-0]|TX|4546/3;3710/3|
00000000|MMI|7.10|Recurrent urinary tract infection|C0262655|[dsyn]|["Urinary tract infection"-tx-7-"urinary tract infection"-noun-0]|TX|[3457/23],[3483/23]|
00000000|MMI|7.10|S prime|C2603362|[clna]|["S'"-tx-23-";"-noun-0,"S'"-tx-5-"("-noun-0]|TX|5459/1;2981/1|
00000000|MMI|7.10|Signal Sensitivity|C2349185|[qlco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|[870/11],[935/11]|
00000000|MMI|7.10|Statistical sensitivity|C0036667|[qnco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|[870/11],[935/11]|
00000000|MMI|7.10|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-53-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|8729/6;175/6|
00000000|MMI|7.10|per second|C0565930|[qnco]|["/s"-tx-23-";"-noun-0,"/s"-tx-5-"("-noun-0]|TX|5459/1;2981/1|
00000000|MMI|7.10|stimulus sensitivity|C1522640|[qlco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|[870/11],[935/11]|
00000000|MMI|7.09|Psittirostra psittacea|C3683509|[bird]|["Ou"-tx-5-"OU"-noun-0,"Ou"-tx-3-"OU"-noun-0]|TX|[1524/2],[1706/2];558/2|
00000000|MMI|7.09|Structure of both eyes|C0229118|[bpoc]|["OU"-tx-5-"OU"-noun-0,"OU"-tx-3-"OU"-noun-0]|TX|[1524/2],[1706/2];558/2|
00000000|MMI|6.83|Blood|C0005767|[tisu]|["Blood"-tx-32-"blood"-noun-0]|TX|6282/5|A12.207.152;A15.145
00000000|MMI|6.83|Edema|C0013604|[fndg]|["OEDEMA"-tx-7-"edema"-noun-0]|TX|3763/5|C23.888.277
00000000|MMI|6.83|enzymology|C0014445|[ftcn]|["enzymes"-tx-19-"enzymes"-noun-0]|TX|4896/7|x.x.x
00000000|MMI|6.77|Appointments|C0003629|[idcn]|["Appointment"-tx-5-"APPOINTMENT"-noun-0]|TX|2970/11|N04.452.095
00000000|MMI|6.75|Heart murmur|C0018808|[fndg]|["MURMUR"-tx-16-"murmur"-noun-0]|TX|4446/6|C23.888.447
00000000|MMI|6.75|Hospitals|C0019994|[hcro,mnob]|["HOSPITAL"-tx-27-"hospital"-noun-0]|TX|5789/8|N02.278.421
00000000|MMI|6.74|inpatient|C0021562|[podg]|["Inpatient"-tx-47-"inpatient"-noun-0]|TX|7718/9|M01.643.470
00000000|MMI|6.74|Netherlands|C0027778|[geoa]|["NL"-tx-37-"nl"-noun-0]|TX|6707/2|Z01.542.651
00000000|MMI|6.70|Anemia|C0002871|[dsyn]|["ANEMIA"-tx-28-"ANEMIA"-noun-0]|TX|5830/6|C15.378.071
00000000|MMI|6.68|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-4-"TAB"-noun-0]|TX|1155/3|D26.255.830
00000000|MMI|6.66|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-19-"ischemia"-noun-1]|TX|4858/8|C23.550.513
00000000|MMI|6.66|Gibraltar|C0017540|[geoa]|["GIB"-tx-30-"GIB"-noun-0]|TX|6031/3|Z01.542.335
00000000|MMI|6.66|Laboratory|C0022877|[mnob,orgt]|["Lab"-tx-32-"lab"-noun-0]|TX|6236/3|N02.278.487
00000000|MMI|5.70|Measures|C0079809|[qnco]|["Measure"-tx-5-"measure"-verb-0]|TX|2783/7|E05.978
00000000|MMI|5.70|Patients|C0030705|[podg]|["*^patient"-tx-5-"Patient"-noun-0]|TX|2768/7|M01.643
00000000|MMI|5.45|Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}|C1316572|[clna]|["Note"-tx-42-"noted"-verb-0,"Note"-tx-36-"noted"-verb-0]|TX|7206/5;6605/5|
00000000|MMI|5.45|Note (document)|C1317574|[inpr]|["Note"-tx-42-"noted"-verb-0,"Note"-tx-36-"noted"-verb-0]|TX|7206/5;6605/5|
00000000|MMI|5.18|Condition|C0348080|[qlco]|["Condition"-tx-51-"CONDITION"-noun-0,"Condition"-tx-7-"Conditions"-noun-0]|TX|8277/9;3288/10|
00000000|MMI|5.18|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-51-"CONDITION"-noun-0,"Condition"-tx-7-"Conditions"-noun-0]|TX|8277/9;3288/10|
00000000|MMI|5.18|Logical Condition|C1705253|[cnce]|["Condition"-tx-51-"CONDITION"-noun-0,"Condition"-tx-7-"Conditions"-noun-0]|TX|8277/9;3288/10|
00000000|MMI|5.15|Weight Gain Adverse Event|C2911647|[fndg]|["Weight gain"-tx-9-"weight gain"-noun-0,"Weight gain"-tx-7-"weight gain"-noun-0]|TX|4003/11;3771/11|
00000000|MMI|5.15|Neurontin|C0678176|[orch,phsu]|["Neurontin"-tx-42-"neurontin"-noun-0,"Neurontin"-tx-5-"NEURONTIN"-noun-0]|TX|7246/9;1427/9|
00000000|MMI|5.13|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-53-"END"-noun-0,"Stop"-tx-49-"stop"-verb-0]|TX|8712/3;7918/4|
00000000|MMI|5.10|Maintaining (action)|C1314677|[ftcn]|["Maintained"-tx-46-"maintained"-verb-0,"Maintained"-tx-22-"maintained"-verb-0]|TX|7507/10;5378/10|
00000000|MMI|5.10|Not Applicable|C1272460|[qlco]|["{NA}"-tx-46-"NA"-noun-0,"NOT APPLICABLE"-tx-2-"Not Applicable"-adj-0]|TX|7523/2;297/14|
00000000|MMI|5.10|Package Type Not Applicable|C4049872|[ftcn]|["NA"-tx-46-"NA"-noun-0,"Not Applicable"-tx-2-"Not Applicable"-adj-0]|TX|7523/2;297/14|
00000000|MMI|5.09|Congestion|C0700148|[patf]|["Congestion"-tx-39-"congestion"-noun-1,"Congestion"-tx-38-"congestion"-noun-1]|TX|6968/10;6749/10|
00000000|MMI|5.09|Sint Maarten (Dutch Part)|C3539997|[geoa]|["SX"-tx-48-"sx's"-noun-0,"SX"-tx-19-"sx's"-noun-0]|TX|7792/4;4729/4|
00000000|MMI|5.09|South Georgia and the South Sandwich Islands|C1519428|[geoa]|["SX"-tx-48-"sx's"-noun-0,"SX"-tx-19-"sx's"-noun-0]|TX|7792/4;4729/4|
00000000|MMI|5.09|Testicular Cancer Serum Markers Test Result SX|C3815196|[lbtr]|["SX"-tx-48-"sx's"-noun-0,"SX"-tx-19-"sx's"-noun-1]|TX|7792/4;4729/4|
00000000|MMI|5.09|Tissue Congestion|C2826600|[fndg]|["CONGESTION"-tx-39-"congestion"-noun-1,"CONGESTION"-tx-38-"congestion"-noun-1]|TX|6968/10;6749/10|
00000000|MMI|5.08|Started|C1272689|[qlco]|["Started"-tx-23-"started"-verb-0,"Started"-tx-9-"started"-verb-0]|TX|5406/7;3933/7|
00000000|MMI|5.04|Groups|C0441833|[idcn]|["Panel"-tx-51-"panel"-noun-0,"Panel"-tx-38-"panel"-noun-0]|TX|8350/5;6824/5|
00000000|MMI|5.04|Laboratory Order Panels|C1999270|[inpr]|["Panel"-tx-51-"panel"-noun-0,"Panel"-tx-38-"panel"-noun-0]|TX|8350/5;6824/5|
00000000|MMI|5.04|Panel Device Component|C3537156|[mnob]|["Panel"-tx-51-"panel"-noun-0,"Panel"-tx-38-"panel"-noun-0]|TX|8350/5;6824/5|
00000000|MMI|5.04|Follow|C1719822|[inpr]|["Follow"-tx-41-"following"-adj-0,"Follow"-tx-5-"follow"-verb-0]|TX|7057/9;2278/6|
00000000|MMI|5.04|Followed by|C0332283|[tmco]|["follow"-tx-41-"following"-adj-0,"follow"-tx-5-"follow"-verb-0]|TX|7057/9;2278/6|
00000000|MMI|5.02|Initially|C0205265|[tmco]|["Initially"-tx-47-"initially"-adv-0,"Initially"-tx-32-"initially"-adv-0]|TX|7613/9;6183/9|
00000000|MMI|5.02|Therapeutic|C0302350|[ftcn]|["Therapeutic"-tx-4-"THERAPEUTIC"-adj-0]|TX|[1114/11],[1128/11]|E02
00000000|MMI|5.00|Increased liver function tests|C0877359|[fndg]|["elevated lft's"-tx-51-"elevated LFT's"-noun-0,"elevated lft's"-tx-36-"elevated LFT's"-noun-0]|TX|8506/14;6619/14|
00000000|MMI|4.97|Gait normal|C0231683|[fndg]|["Normal"-tx-29-"normal"-adj-0,"Normal"-tx-28-"normal"-adj-0]|TX|5936/6;5887/6|
00000000|MMI|4.97|Mean Percent of Normal|C2347086|[qnco]|["% Normal"-tx-29-"normal"-adj-0,"% Normal"-tx-28-"normal"-adj-0]|TX|5936/6;5887/6|
00000000|MMI|4.97|Normal|C0205307|[qlco]|["NORMAL"-tx-29-"normal"-adj-0,"NORMAL"-tx-28-"normal"-adj-0]|TX|5936/6;5887/6|
00000000|MMI|4.97|Percent normal|C0439166|[qnco]|["% normal"-tx-29-"normal"-adj-0,"% normal"-tx-28-"normal"-adj-0]|TX|5936/6;5887/6|
00000000|MMI|4.97|Stool seat|C0183622|[medd]|["Stool"-tx-51-"stool"-noun-0,"Stool"-tx-29-"stool"-noun-0]|TX|8405/5;5915/5|
00000000|MMI|4.95|Stools:Appearance:Point in time:Lower GI tract:Nominal|C0489144|[clna]|["Stools"-tx-51-"stools"-noun-0,"Stools"-tx-49-"stools"-noun-0]|TX|8542/6;8086/6|
00000000|MMI|4.95|Summary (document)|C1706244|[inpr]|["Summary"-tx-52-"summary"-noun-0,"Summary"-tx-2-"SUMMARY"-noun-0]|TX|8631/7;346/7|
00000000|MMI|4.95|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-52-"summary"-noun-0,"summary"-tx-2-"SUMMARY"-noun-0]|TX|8631/7;346/7|
00000000|MMI|4.93|Science of Etiology|C1524003|[cnce]|["Etiology"-tx-40-"etiology"-noun-0,"Etiology"-tx-19-"Etiology"-noun-0]|TX|6993/8;4642/8|
00000000|MMI|4.93|Presentation|C0449450|[idcn]|["Present"-tx-12-"present"-adj-0,"Presented"-tx-12-"presented"-verb-0]|TX|4192/7;4215/9|
00000000|MMI|4.92|Adelina|C0320478|[euka]|["Adelina"-tx-5-"ADELINA"-noun-0,"Adelina"-tx-4-"ADELINA"-noun-0]|TX|2123/7;1224/7|
00000000|MMI|4.92|HP gene|C1415692|[gngm]|["Bp"-tx-23-"BP's"-noun-0,"Bp"-tx-13-"BP"-noun-0]|TX|5430/4;4269/2|
00000000|MMI|4.92|HP wt Allele|C1708288|[gngm]|["BP"-tx-23-"BP's"-noun-0,"BP"-tx-13-"BP"-noun-0]|TX|5430/4;4269/2|
00000000|MMI|4.90|Negative - answer|C3853545|[qlco]|["Negative"-tx-19-"negative"-adj-0,"NEG"-tx-14-"neg"-noun-0]|TX|4887/8;4343/3|
00000000|MMI|4.90|Well|C3146287|[mnob]|["Well"-tx-27-"well"-adv-0,"Well"-tx-9-"well"-adv-0]|TX|5707/4;3906/4|
00000000|MMI|4.88|Continuous|C0549178|[idcn]|["Continued"-tx-42-"continued"-verb-0,"Continued"-tx-26-"continued"-verb-0]|TX|7137/9;5616/9|
00000000|MMI|4.86|10%|C3842590|[fndg]|["10%"-tx-5-"10"-integer-0]|TX|[1672/2],[1755/2]|
00000000|MMI|4.86|60%|C3842585|[fndg]|["60%"-tx-7-"60"-percentage-0,"60%"-tx-2-"60"-integer-0]|TX|3685/2;215/2|
00000000|MMI|4.84|70%|C3842584|[fndg]|["70%"-tx-5-"70"-fraction-0,"70%"-tx-5-"70"-integer-0]|TX|[1393/2],[1411/2];[1393/2],[1411/2]|
00000000|MMI|4.84|Excellent (qualifier value)|C1961136|[qlco]|["Excellent"-tx-39-"excellent"-adj-0,"Excellent"-tx-20-"excellent"-adj-0]|TX|6905/9;4981/9|
00000000|MMI|4.84|Excellent - Specimen Quality|C1548784|[qlco]|["Excellent"-tx-39-"excellent"-adj-0,"Excellent"-tx-20-"excellent"-adj-0]|TX|6905/9;4981/9|
00000000|MMI|4.83|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-5-"PUO"-noun-0,"puo"-tx-1-"PUO"-noun-0]|TX|2683/3;12/3|
00000000|MMI|4.81|Sodium Cation|C0597484|[elii]|["Na+"-tx-46-"NA"-noun-0,"Sodium+"-tx-5-"Sodium"-noun-0]|TX|7523/2;2919/6|
00000000|MMI|4.80|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-7-"RESUME"-noun-0,"Resume"-tx-5-"Resume"-noun-0]|TX|3596/6;2936/6|
00000000|MMI|4.80|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-7-"RESUME"-noun-0,"Resume"-tx-5-"Resume"-noun-0]|TX|3596/6;2936/6|
00000000|MMI|4.80|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-7-"RESUME"-noun-0,"resume"-tx-5-"Resume"-noun-0]|TX|3596/6;2936/6|
00000000|MMI|4.79|Discontinued|C1444662|[fndg]|["D/C"-tx-2-"D/C"-noun-1,"DIS"-tx-1-"DIS"-noun-0]|TX|317/3;86/3|
00000000|MMI|4.78|Changed status|C0443172|[qnco]|["Changed"-tx-27-"changed"-verb-0,"changes"-tx-14-"changes"-noun-0]|TX|5778/7;4329/7|
00000000|MMI|4.78|Changing|C0392747|[ftcn]|["Changed"-tx-27-"changed"-verb-0,"changes"-tx-14-"changes"-noun-0]|TX|5778/7;4329/7|
00000000|MMI|4.78|Code|C0805701|[inpr]|["CODE"-tx-3-"CODE"-noun-0,"CODE"-tx-3-"code"-noun-0]|TX|402/4;420/4|
00000000|MMI|4.78|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-3-"CODE"-noun-0,"Code"-tx-3-"code"-noun-0]|TX|402/4;420/4|
00000000|MMI|4.78|Patient Outcome - Worsening|C1546960|[idcn]|["Worsening"-tx-50-"worsening"-adj-0,"Worsening"-tx-19-"worsening"-noun-0]|TX|8131/9;4699/9|
00000000|MMI|4.78|Worse|C1457868|[fndg]|["Worsening"-tx-50-"worsening"-adj-0,"Worsening"-tx-19-"worsening"-noun-1]|TX|8131/9;4699/9|
00000000|MMI|4.78|Worsening pattern|C0332271|[qlco]|["Worsening"-tx-50-"worsening"-adj-0,"Worsening"-tx-19-"worsening"-noun-0]|TX|8131/9;4699/9|
00000000|MMI|4.78|physiologic resolution|C1514893|[patf]|["Resolved"-tx-34-"resolved"-verb-0,"Resolution"-tx-32-"resolution"-noun-0]|TX|6420/8;6259/10|
00000000|MMI|4.76|/40|C0439509|[tmco]|["/40"-tx-36-"40"-integer-0,"/40"-tx-7-"40"-integer-0]|TX|6592/2;3063/2|
00000000|MMI|4.76|40%|C3842587|[qnco]|["40%"-tx-36-"40"-integer-0,"40%"-tx-7-"40"-integer-0]|TX|6592/2;3063/2|
00000000|MMI|4.76|Importance Weight|C1705104|[idcn]|["Weight"-tx-22-"weight"-noun-0,"Weight"-tx-5-"weight"-noun-0]|TX|5337/6;2791/6|
00000000|MMI|4.76|Regular|C0205272|[qlco]|["Regular"-tx-5-"REGULAR"-adj-0]|TX|[2414/7],[2546/7]|
00000000|MMI|4.76|Weighing patient|C1305866|[diap]|["weight"-tx-22-"weight"-noun-0,"weight"-tx-5-"weight"-noun-0]|TX|5337/6;2791/6|
00000000|MMI|4.76|Weight|C0043100|[qnco]|["WEIGHT"-tx-22-"weight"-noun-0,"WEIGHT"-tx-5-"weight"-noun-0]|TX|5337/6;2791/6|
00000000|MMI|4.75|Hepatotoxicity|C0235378|[inpo]|["Hepatotoxicity"-tx-42-"hepatotoxicity"-noun-0,"Hepatotoxicity"-tx-41-"hepatotoxic"-adj-0]|TX|7191/14;7067/11|
00000000|MMI|4.74|microgram|C0439211|[qnco]|["mcg"-tx-5-"MCG"-noun-0,"mcg"-tx-3-"MCG"-noun-0]|TX|2499/3;691/3|
00000000|MMI|4.74|miscellaneous Crenarchaeota group|C3463985|[arch]|["MCG"-tx-5-"MCG"-noun-0,"MCG"-tx-3-"MCG"-noun-0]|TX|2499/3;691/3|
00000000|MMI|4.74|Picofarad (unit of measure)|C1882376|[qnco]|["Puff"-tx-5-"PUFF"-noun-0]|TX|[1812/4],[2350/4]|
00000000|MMI|4.74|Puff unit dose|C1533107|[qnco]|["PUFF"-tx-5-"PUFF"-noun-0]|TX|[1812/4],[2350/4]|
00000000|MMI|4.74|House (environment)|C2003847|[mnob]|["House"-tx-5-"House"-noun-0]|TX|[2844/5],[2881/5]|
00000000|MMI|4.73|K Prime|C1708601|[qnco]|["K'"-tx-45-"K"-noun-0]|TX|[7454/1],[7496/1]|
00000000|MMI|4.73|Potassium Ion|C0597277|[elii,phsu]|["K+"-tx-45-"K"-noun-0]|TX|[7454/1],[7496/1]|
00000000|MMI|4.73|Low Mitosis-Karyorrhexis Index|C3890211|[qnco]|["Low"-tx-29-"low"-adj-0,"Low"-tx-23-"low"-adj-0]|TX|5932/3;5438/3|
00000000|MMI|4.73|Positive|C1446409|[qlco]|["Positive"-tx-49-"positive"-adj-0,"Positive"-tx-29-"positive"-adj-0]|TX|8077/8;5906/8|
00000000|MMI|4.73|Positive Charge|C2825490|[qlco]|["Positive"-tx-49-"positive"-adj-0,"Positive"-tx-29-"positive"-adj-0]|TX|8077/8;5906/8|
00000000|MMI|4.73|Positive Finding|C1514241|[fndg]|["POSITIVE"-tx-49-"positive"-adj-0,"POSITIVE"-tx-29-"positive"-adj-0]|TX|8077/8;5906/8|
00000000|MMI|4.73|Positive Number|C3812269|[cnce]|["Positive"-tx-49-"positive"-adj-0,"Positive"-tx-29-"positive"-adj-0]|TX|8077/8;5906/8|
00000000|MMI|4.73|low|C0205251|[qlco]|["Low"-tx-29-"low"-adj-0,"Low"-tx-23-"low"-adj-0]|TX|5932/3;5438/3|
00000000|MMI|4.73|low confidentiality|C1550472|[inpr]|["low"-tx-29-"low"-adj-0,"low"-tx-23-"low"-adj-0]|TX|5932/3;5438/3|
00000000|MMI|4.73|low exposure|C4048187|[qlco]|["low"-tx-29-"low"-adj-0,"low"-tx-23-"low"-adj-0]|TX|5932/3;5438/3|
00000000|MMI|4.73|percent positive cells|C0439178|[qnco]|["% Positive"-tx-49-"positive"-adj-0,"% Positive"-tx-29-"positive"-adj-0]|TX|8077/8;5906/8|
00000000|MMI|4.72|mEq|C0439152|[qnco]|["mEq"-tx-5-"MEQ"-noun-0,"mEq"-tx-5-"mEq"-noun-0]|TX|2661/3;2722/3|
00000000|MMI|4.71|Every evening|C0585330|[tmco]|["QPM"-tx-5-"QPM"-noun-0]|TX|[1709/3],[2442/3]|
00000000|MMI|4.71|Once a day, in the evening|C1275568|[tmco]|["qPM"-tx-5-"QPM"-noun-0]|TX|[1709/3],[2442/3]|
00000000|MMI|4.71|Three times daily|C0556984|[tmco]|["TID"-tx-20-"TID"-noun-0,"TID"-tx-5-"TID"-noun-0]|TX|4963/3;1462/3|
00000000|MMI|4.71|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-20-"TID"-noun-0,"TID"-tx-5-"TID"-noun-0]|TX|4963/3;1462/3|
00000000|MMI|4.70|Myocardial Infarction ECG Assessment|C3810814|[diap]|["MI"-tx-19-"MI"-noun-0]|TX|[4691/2],[4879/2]|
00000000|MMI|4.67|Enzymes|C0014442|[enzy,orch]|["ENZYMES"-tx-19-"enzymes"-noun-0]|TX|4896/7|D08.811
00000000|MMI|4.67|Salts|C0036140|[chvs]|["Salt"-tx-22-"salt"-noun-0]|TX|5356/4|D01.786
00000000|MMI|4.67|Adverse reaction to drug|C0041755|[inpo]|["DRUG REACTION"-tx-40-"reaction drug"-noun-0]|TX|7017/8,7029/4|C25.100
00000000|MMI|4.64|Case Reports Publication Type|C0007320|[inpr]|["Case Reports"-tx-42-"case reports"-noun-0]|TX|7175/12|V03.100
00000000|MMI|4.64|Body Fluids|C0005889|[bdsu]|["FLUID"-tx-22-"fluid"-noun-0]|TX|5346/5|A12.207
00000000|MMI|4.63|Policy|C0242456|[inpr]|["Policy"-tx-5-"Policy"-noun-0]|TX|2706/6|I01.655;N03.623
00000000|MMI|4.59|Heart|C0018787|[bpoc]|["Cardiac"-tx-46-"cardiac"-adj-0]|TX|7564/7|A07.541
00000000|MMI|4.52|Woman|C0043210|[popg]|["WOMAN"-tx-18-"woman"-noun-0]|TX|4515/5|M01.975
00000000|MMI|4.51|Inhaler|C0021461|[medd]|["INHALER"-tx-5-"INHALER"-noun-0]|TX|2336/7|E07.605
00000000|MMI|3.54|% volume (qualifier value)|C1690016|[qlco]|["% vol"-tx-18-"vol"-noun-0]|TX|4597/3|
00000000|MMI|3.54|90%|C3842582|[fndg]|["90%"-tx-23-"90"-integer-0]|TX|5457/2|
00000000|MMI|3.54|<90|C0439087|[qnco]|["<90"-tx-23-"90"-integer-0]|TX|5457/2|
00000000|MMI|3.54|>90|C0439083|[qnco]|[">90"-tx-23-"90"-integer-0]|TX|5457/2|
00000000|MMI|3.54|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-16-"abd"-noun-0]|TX|4469/3|
00000000|MMI|3.54|AKR1C3 gene|C1412326|[gngm]|["DDX"-tx-38-"DDX"-noun-0]|TX|6736/3|
00000000|MMI|3.54|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-5-"Patient"-noun-0]|TX|2768/7|
00000000|MMI|3.54|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-16-"abd"-noun-0]|TX|4469/3|
00000000|MMI|3.54|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-7-"OPERATIONS"-noun-0]|TX|3509/10|
00000000|MMI|3.54|Additional comments|C1830770|[fndg]|["Additional comments"-tx-49-"ADDITIONAL COMMENTS"-noun-0]|TX|7887/19|
00000000|MMI|3.54|Admission Level of Care Code - Improved|C1561611|[inpr]|["Improved"-tx-48-"improved"-verb-0]|TX|7802/8|
00000000|MMI|3.54|Affecting|C0392760|[ftcn]|["Affecting"-tx-7-"affecting"-verb-0]|TX|3330/9|
00000000|MMI|3.54|Associated Persons Domain|C3887950|[inpr]|["AP"-tx-37-"AP"-noun-0]|TX|6695/2|
00000000|MMI|3.54|Atlantic Standard Time|C3891303|[tmco]|["AST"-tx-37-"AST"-noun-0]|TX|6684/3|
00000000|MMI|3.54|Better|C0332272|[qlco]|["Improved"-tx-48-"improved"-verb-0]|TX|7802/8|
00000000|MMI|3.54|Body Site Modifier - Lower|C1548802|[blor]|["Lower"-tx-28-"lower"-verb-0]|TX|5872/5|
00000000|MMI|3.54|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-50-"call"-verb-0]|TX|8236/4|
00000000|MMI|3.54|Complication|C0009566|[patf]|["Complications"-tx-7-"Complications"-noun-0]|TX|3314/13|
00000000|MMI|3.54|Cyanocobalamin Drug Class|C3714801|[phsu,vita]|["CYANOCOBALAMIN"-tx-5-"CYANOCOBALAMIN"-noun-0]|TX|2474/14|
00000000|MMI|3.54|Decision|C0679006|[menp]|["Call"-tx-50-"call"-verb-0]|TX|8236/4|
00000000|MMI|3.54|Diagnostic, Therapeutic, and Research Equipment|C1523994|[mnob]|["Equipment"-tx-27-"equipment"-noun-0]|TX|5810/9|
00000000|MMI|3.54|Dietary indiscretion|C1321006|[fndg]|["Dietary indiscretion"-tx-19-"dietary indiscretion"-noun-1]|TX|4766/20|
00000000|MMI|3.54|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|133/14|
00000000|MMI|3.54|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|133/14|
00000000|MMI|3.54|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-13-"ED"-noun-0]|TX|4264/2|
00000000|MMI|3.54|Equipment|C0014672|[mnob]|["Equipment"-tx-27-"equipment"-noun-0]|TX|5810/9|E07
00000000|MMI|3.54|Equipment used|C0220824|[mnob]|["equipment"-tx-27-"equipment"-noun-0]|TX|5810/9|
00000000|MMI|3.54|Fluticasone propionate|C0117996|[orch,phsu]|["FLUTICASONE PROPIONATE"-tx-5-"FLUTICASONE PROPIONATE"-noun-0]|TX|1781/22|
00000000|MMI|3.54|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-7-"OPERATIONS"-noun-0]|TX|3509/10|
00000000|MMI|3.54|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-5-"Patient"-noun-0]|TX|2768/7|
00000000|MMI|3.54|Impression|C1998467|[qlco]|["Impression"-tx-18-"Impression"-noun-0]|TX|4498/10|
00000000|MMI|3.54|Improved|C0184511|[qlco]|["Improved"-tx-48-"improved"-verb-0]|TX|7802/8|
00000000|MMI|3.54|Information|C1533716|[idcn]|["INFORMATION"-tx-5-"information"-noun-0]|TX|2068/11|
00000000|MMI|3.54|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-7-"PROCEDURES"-noun-0]|TX|3524/10|
00000000|MMI|3.54|Involvement with|C1314939|[ftcn]|["Affecting"-tx-7-"affecting"-verb-0]|TX|3330/9|
00000000|MMI|3.54|Lower (action)|C2003888|[acty]|["Lower"-tx-28-"lower"-verb-0]|TX|5872/5|
00000000|MMI|3.54|Lower - spatial qualifier|C0441994|[spco]|["LOWER"-tx-28-"lower"-verb-0]|TX|5872/5|
00000000|MMI|3.54|MANEA gene|C1427293|[gngm]|["ENDO"-tx-47-"ENDO"-adj-0]|TX|7594/4|
00000000|MMI|3.54|Measurement|C0242485|[ftcn]|["Measure"-tx-5-"measure"-verb-0]|TX|2783/7|
00000000|MMI|3.54|Most|C0205393|[qnco]|["Much"-tx-48-"much"-adv-0]|TX|7797/4|
00000000|MMI|3.54|Normalize|C1882115|[resa]|["Normalize"-tx-42-"normalize"-verb-0]|TX|7277/9|
00000000|MMI|3.54|On admission|C0457453|[tmco]|["On admission"-tx-10-"On admission"-adj-0]|TX|4029/12|
00000000|MMI|3.54|Orthopnea|C0085619|[sosy]|["Orthopnoea"-tx-9-"orthopnea"-noun-0]|TX|3980/9|
00000000|MMI|3.54|Percent Volume per Volume|C3887614|[qnco]|["vol%"-tx-18-"vol"-noun-0]|TX|4597/3|
00000000|MMI|3.54|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-7-"PROCEDURES"-noun-0]|TX|3524/10|
00000000|MMI|3.54|Pulmonary ventilator management|C1315068|[hlca]|["PULM"-tx-26-"Pulm"-adj-0]|TX|5603/4|
00000000|MMI|3.54|Pump Device Component|C1706421|[mnob]|["Pump"-tx-20-"PUMP"-noun-0]|TX|4906/4|
00000000|MMI|3.54|Radiologic Impression|C4049863|[fndg]|["Impression"-tx-18-"Impression"-noun-0]|TX|4498/10|
00000000|MMI|3.54|Renal Failure Adverse Event|C1963154|[patf]|["Renal failure"-tx-18-"renal failure"-noun-0]|TX|4626/13|
00000000|MMI|3.54|Rhythm|C0871269|[fndg]|["Rhythm"-tx-24-"RHYTHM"-noun-0]|TX|5464/6|
00000000|MMI|3.54|Rhythm Not Otherwise Specified ECG Assessment|C3828331|[inpr]|["Rhythm Not Otherwise Specified"-tx-24-"RHYTHM"-noun-0]|TX|5464/6|
00000000|MMI|3.54|Scientific Equipment|C2827396|[mnob]|["Equipment"-tx-27-"equipment"-noun-0]|TX|5810/9|
00000000|MMI|3.54|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-5-"Patient"-noun-0]|TX|2768/7|
00000000|MMI|3.54|Stop (Instruction Imperative)|C1947925|[acty]|["Stop"-tx-49-"stop"-verb-0]|TX|7918/4|
00000000|MMI|3.54|Swollen legs|C0581394|[sosy]|["lower extremity swelling"-tx-50-"lower extremity swelling"-noun-0]|TX|8173/24|
00000000|MMI|3.54|TOCOPHEROL,DL-ALPHA|C1323100|[orch,phsu,vita]|["TOCOPHEROL,DL-ALPHA"-tx-4-"TOCOPHEROL-DL-ALPHA"-noun-0]|TX|1063/19|
00000000|MMI|3.54|Unlikely|C0750558|[cnce]|["Unlikely"-tx-38-"unlikely"-adj-0]|TX|6807/8|
00000000|MMI|3.54|Unlikely Related to Intervention|C1710571|[qlco]|["Unlikely"-tx-38-"unlikely"-adj-0]|TX|6807/8|
00000000|MMI|3.54|VIT gene|C1421454|[gngm]|["VIT"-tx-4-"VIT"-noun-0]|TX|1315/3|
00000000|MMI|3.54|Vitamin B3 Assay|C1142562|[lbpr]|["Niacin"-tx-4-"NIACIN"-noun-0]|TX|1306/6|
00000000|MMI|3.54|Vitamin C Drug Class|C3714687|[phsu,vita]|["VITAMIN C"-tx-3-"VITAMIN C"-noun-0]|TX|478/9|
00000000|MMI|3.54|Vitamin C Vitamins|C2349136|[orch,vita]|["Vitamin C"-tx-3-"VITAMIN C"-noun-0]|TX|478/9|
00000000|MMI|3.54|Volume|C0449468|[qnco]|["VOL"-tx-18-"vol"-noun-0]|TX|4597/3|
00000000|MMI|3.54|consideration|C0518609|[fndg]|["Consideration"-tx-42-"consideration"-noun-0]|TX|7219/13|
00000000|MMI|3.54|dvt prophylaxis|C0853245|[topp]|["dvt prophylaxis"-tx-36-"DVT prophylaxis"-noun-0]|TX|6565/15|
00000000|MMI|3.54|impression (attitude)|C0596764|[inbe]|["impression"-tx-18-"Impression"-noun-0]|TX|4498/10|
00000000|MMI|3.54|pump (device)|C0182537|[medd]|["Pump"-tx-20-"PUMP"-noun-0]|TX|4906/4|
00000000|MMI|3.54|rhythmic process (biological)|C1523018|[phsf]|["rhythm"-tx-24-"RHYTHM"-noun-0]|TX|5464/6|
00000000|MMI|3.54|suggestion|C1705535|[idcn]|["Suggest"-tx-19-"suggest"-verb-0]|TX|4758/7|
00000000|MMI|3.54|symptomatic relief|C3242309|[idcn]|["symptomatic relief"-tx-8-"symptomatic relief"-noun-0]|TX|3870/18|
00000000|MMI|3.54|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-7-"TREATMENTS/PROCEDURES"-noun-0]|TX|3547/21|
00000000|MMI|2.72|Appearance|C0700364|[qlco]|["APPEAR"-tx-32-"appeared"-verb-0]|TX|6221/8|
00000000|MMI|2.72|Beginning|C0439659|[tmco]|["Begin"-tx-42-"began"-verb-0]|TX|7268/5|
00000000|MMI|2.72|Show|C1547282|[anim]|["Show"-tx-14-"showed"-verb-0]|TX|4306/6|
00000000|MMI|2.72|With configuration|C0449830|[spco]|["Arrangement"-tx-27-"arrangements"-noun-0]|TX|5723/12|
00000000|MMI|2.60|3+ pitting edema|C1720001|[fndg]|["3+ pitting oedema"-tx-17-"3 pitting edema"-noun-0]|TX|4476/1,4479/7,4490/5|
00000000|MMI|2.60|Humulin 70/30|C0306367|[aapp,horm,phsu]|["Humulin 70/30"-tx-5-"HUMULIN 70/30"-noun-0]|TX|1369/13|
00000000|MMI|2.58|TDGF1P4 gene|C3469969|[gngm]|["CR-4"-tx-15-"Cr 4"-noun-0]|TX|4370/2,4375/1|
00000000|MMI|2.57|Nasal Spray|C0461725|[bodm]|["Nasal Spray"-tx-5-"NASAL SPRAY"-noun-0]|TX|1598/11|
00000000|MMI|2.56|Acute-on-chronic renal failure|C0403462|[dsyn]|["Acute-on-chronic renal failure"-tx-33-"acute on chronic renal failure"-noun-0]|TX|6322/30|
00000000|MMI|2.54|Blood vitamin B6 analysis|C0696232|[lbpr]|["vitamin b 6"-tx-4-"VITAMIN B 6"-noun-0]|TX|1008/11|
00000000|MMI|2.52|Shortness of breath:-:Point in time:^Patient:-|C2707305|[clna]|["Shortness of breath"-tx-50-"shortness of breath"-noun-0]|TX|8141/19|
00000000|MMI|2.52|Adult female goat|C3668950|[mamm]|["Doe"-tx-9-"DOE"-noun-0]|TX|3964/3|
00000000|MMI|2.52|At|C1516077|[spco]|["At"-tx-27-"at"-adj-0]|TX|5770/2|
00000000|MMI|2.52|Attending (action)|C1999232|[ftcn]|["attending"-tx-2-"Attending"-noun-0]|TX|359/9|
00000000|MMI|2.52|Attending (provider role)|C1547429|[prog]|["Attending"-tx-2-"Attending"-noun-0]|TX|359/9|
00000000|MMI|2.52|Axial R|C3538806|[spco]|["Ra"-tx-13-"RA"-noun-0]|TX|4290/2|
00000000|MMI|2.52|Basilar Rales|C0240859|[fndg]|["Rales"-tx-16-"rales"-noun-0]|TX|4461/5|
00000000|MMI|2.52|CR2 gene|C1413696|[gngm]|["CR2"-tx-15-"Cr 2"-noun-0]|TX|4388/2,4392/1|
00000000|MMI|2.52|Complement Receptor Type 2|C3539605|[aapp,rcpt]|["Cr2"-tx-15-"Cr 2"-noun-0]|TX|4388/2,4392/1|
00000000|MMI|2.52|Department of Energy|C1511776|[prog]|["DOE"-tx-9-"DOE"-noun-0]|TX|3964/3|
00000000|MMI|2.52|Disease Response|C1704632|[fndg]|["Response"-tx-20-"response"-noun-0]|TX|4991/8|
00000000|MMI|2.52|Distress|C0231303|[menp]|["Distress"-tx-15-"distress"-noun-0]|TX|4414/8|
00000000|MMI|2.52|Dyspnea on exertion|C0231807|[sosy]|["DOE"-tx-9-"DOE"-noun-0]|TX|3964/3|
00000000|MMI|2.52|ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS|C3540048|[enzy,phsu]|["ENZYMES"-tx-19-"enzymes"-noun-0]|TX|4896/7|
00000000|MMI|2.52|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-7-"edema"-noun-0]|TX|3763/5|
00000000|MMI|2.52|Elevation procedure|C0439775|[topp]|["Elevation"-tx-34-"elevation"-noun-0]|TX|6400/9|
00000000|MMI|2.52|Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|C3540772|[enzy,phsu]|["Enzymes"-tx-19-"enzymes"-noun-0]|TX|4896/7|
00000000|MMI|2.52|Enzymes for ALIMENTARY TRACT AND METABOLISM|C3542456|[enzy,phsu]|["Enzymes"-tx-19-"enzymes"-noun-0]|TX|4896/7|
00000000|MMI|2.52|Enzymes, antithrombotic|C3541394|[enzy,phsu]|["Enzymes"-tx-19-"enzymes"-noun-0]|TX|4896/7|
00000000|MMI|2.52|Enzymes, hematological|C3540017|[enzy,phsu]|["Enzymes"-tx-19-"enzymes"-noun-0]|TX|4896/7|
00000000|MMI|2.52|Enzymes, peripheral vasodilators|C3540790|[enzy,phsu]|["Enzymes"-tx-19-"enzymes"-noun-0]|TX|4896/7|
00000000|MMI|2.52|FST wt Allele|C3814419|[gngm]|["FS"-tx-47-"FS"-noun-0]|TX|7751/2|
00000000|MMI|2.52|French Southern Territories|C1517317|[geoa]|["FS"-tx-47-"FS"-noun-0]|TX|7751/2|
00000000|MMI|2.52|GATM wt Allele|C4049625|[gngm]|["AT"-tx-27-"at"-adj-0]|TX|5770/2|
00000000|MMI|2.52|NEB gene|C1417656|[gngm]|["NEB"-tx-26-"nebs"-noun-0]|TX|5661/4|
00000000|MMI|2.52|Nebulizer solution|C1300458|[bodm]|["Nebs"-tx-26-"nebs"-noun-0]|TX|5661/4|
00000000|MMI|2.52|On (qualifier value)|C1720294|[inpr]|["On"-tx-42-"on"-adj-0]|TX|7287/2|
00000000|MMI|2.52|P Blood group antibodies|C0369773|[aapp,imft]|["P NOS"-tx-13-"P"-noun-0]|TX|4280/1|
00000000|MMI|2.52|P prime|C2603361|[clna]|["P'"-tx-13-"P"-noun-0]|TX|4280/1|
00000000|MMI|2.52|Response (communication)|C2911692|[menp]|["Response"-tx-20-"response"-noun-0]|TX|4991/8|
00000000|MMI|2.52|Response (statement)|C1706817|[inpr]|["Response"-tx-20-"response"-noun-0]|TX|4991/8|
00000000|MMI|2.52|Response process|C0871261|[orga]|["Response"-tx-20-"response"-noun-0]|TX|4991/8|
00000000|MMI|2.52|Restricted|C0443288|[ftcn]|["Restriction"-tx-22-"restriction"-noun-0]|TX|5361/11|
00000000|MMI|2.52|Right arm|C4048756|[bpoc]|["RA"-tx-13-"RA"-noun-0]|TX|4290/2|
00000000|MMI|2.52|Status|C0449438|[qlco]|["Status"-tx-3-"STATUS"-noun-0]|TX|407/6|
00000000|MMI|2.52|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-50-"symptoms"-noun-0]|TX|8218/8|
00000000|MMI|2.52|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-50-"symptoms"-noun-0]|TX|8218/8|
00000000|MMI|2.52|TDGF1P2 gene|C3469967|[gngm]|["CR-2"-tx-15-"Cr 2"-noun-0]|TX|4388/2,4392/1|
00000000|MMI|2.52|Upon - dosing instruction fragment|C1720176|[ftcn]|["On"-tx-42-"on"-adj-0]|TX|7287/2|
00000000|MMI|2.52|Wild Type Unspecified - zebrafish|C2700323|[fish]|["WT"-tx-21-"wt"-noun-0]|TX|5178/2|
00000000|MMI|2.52|Xalatan|C0593887|[orch,phsu]|["Xalatan"-tx-5-"XALATAN"-noun-0]|TX|1675/7|
00000000|MMI|2.52|medication - HL7 publishing domain|C3244316|[ftcn]|["medication"-tx-42-"medication"-adj-0]|TX|7290/10|
00000000|MMI|2.52|peripheral blood|C0229664|[bdsu]|["BLOOD"-tx-32-"blood"-noun-0]|TX|6282/5|
00000000|MMI|2.51|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-7-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|3176/9,3196/9|
00000000|MMI|2.51|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-7-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|3176/9,3196/9|
00000000|MMI|2.49|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|92/14|
00000000|MMI|2.49|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|92/14|
00000000|MMI|2.49|Dyspnea, progressive|C0239202|[fndg]|["DYSPNEA, PROGRESSIVE"-tx-7-"progressive dyspnea"-noun-0]|TX|3724/19|
00000000|MMI|2.49|Progressive breathing difficulty|C3806899|[fndg]|["Progressive Dyspnoea"-tx-7-"progressive dyspnea"-noun-0]|TX|3724/19|
00000000|MMI|2.49|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|118/13|
00000000|MMI|2.49|Weight Loss Adverse Event|C2911645|[patf]|["Weight loss"-tx-8-"weight loss"-noun-0]|TX|3854/11|
00000000|MMI|2.49|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-7-"DISCHARGE DIAGNOSIS"-noun-0]|TX|3186/19|
00000000|MMI|2.49|10 - 12|C3843787|[fndg]|["10 - 12"-tx-1-"10 12"-fraction-0]|TX|41/2,51/2|
00000000|MMI|2.49|3/6|C0442759|[fndg]|["3 6"-tx-16-"3/6"-fraction-0]|TX|4439/3|
00000000|MMI|2.49|Entered|C1521975|[qlco]|["Entered"-tx-52-"ENTERED"-verb-0]|TX|8639/7|
00000000|MMI|2.49|Secondary to|C0175668|[tmco]|["Secondary to"-tx-33-"secondary to"-adj-0]|TX|6364/12|
00000000|MMI|2.48|Act Relationship Subset - previous|C1552607|[tmco]|["previous"-tx-5-"Previous"-adj-0]|TX|2050/8|
00000000|MMI|2.48|Disposition|C0743223|[idcn]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|425/11|
00000000|MMI|2.48|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|425/11|
00000000|MMI|2.48|Dosage|C0178602|[qnco]|["DOSE"-tx-5-"dose"-noun-0]|TX|2726/4|
00000000|MMI|2.48|Exacerbation of cGVHD|C3540542|[fndg]|["Flare"-tx-12-"flare"-noun-0]|TX|4231/5|
00000000|MMI|2.48|Flare|C1517205|[sosy]|["Flare"-tx-12-"flare"-noun-0]|TX|4231/5|
00000000|MMI|2.48|Fluid behavior|C0444611|[qlco]|["Fluid"-tx-22-"fluid"-noun-0]|TX|5346/5|
00000000|MMI|2.48|Insulin Drug Class|C3714501|[horm,phsu]|["INSULIN"-tx-5-"INSULIN"-noun-0]|TX|1385/7|
00000000|MMI|2.48|Insulin [EPC]|C1579433|[phsu]|["Insulin"-tx-5-"INSULIN"-noun-0]|TX|1385/7|
00000000|MMI|2.48|Liquid substance|C0302908|[sbst]|["fluid"-tx-22-"fluid"-noun-0]|TX|5346/5|
00000000|MMI|2.48|Previous|C0205156|[tmco]|["Previous"-tx-5-"Previous"-adj-0]|TX|2050/8|
00000000|MMI|2.48|Recombinant Insulin|C1533581|[aapp,horm,phsu]|["INSULIN"-tx-5-"INSULIN"-noun-0]|TX|1385/7|
00000000|MMI|2.48|Unit dose|C0869039|[qnco]|["Dose"-tx-5-"dose"-noun-0]|TX|2726/4|
00000000|MMI|2.48|Vitamin E Drug Class|C3714803|[phsu,vita]|["VITAMIN E"-tx-4-"VITAMIN E"-noun-0]|TX|1051/9|
00000000|MMI|2.48|fluid - substance|C1704353|[sbst]|["Fluid"-tx-22-"fluid"-noun-0]|TX|5346/5|
00000000|MMI|2.47|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2926/8|
00000000|MMI|2.47|Active|C0205177|[ftcn]|["Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2926/8|
00000000|MMI|2.47|Activities|C0441655|[acty]|["ACTIVITY"-tx-5-"ACTIVITY"-noun-0]|TX|2926/8|
00000000|MMI|2.47|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2926/8|
00000000|MMI|2.47|Baseline|C1442488|[qnco]|["Baseline"-tx-15-"baseline"-noun-0]|TX|4379/8|
00000000|MMI|2.47|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-5-"ACTIVITY"-noun-0]|TX|2926/8|
00000000|MMI|2.47|Ferric|C2346593|[elii]|["Fe+++"-tx-29-"Fe"-noun-0]|TX|5943/2|
00000000|MMI|2.47|Percent Activity|C0439167|[qnco]|["% Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2926/8|
00000000|MMI|2.47|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-5-"ACTIVITY"-noun-0]|TX|2926/8|
00000000|MMI|2.47|Planned|C1301732|[ftcn]|["Plan"-tx-51-"PLAN"-noun-0]|TX|8301/4|
00000000|MMI|2.47|RF|C0748398|[fndg]|["RF"-tx-12-"RF"-noun-0]|TX|4256/2|
00000000|MMI|2.47|Rheumatoid Factor Measurement|C0201660|[lbpr]|["RF"-tx-12-"RF"-noun-0]|TX|4256/2|
00000000|MMI|2.47|Scientific Study|C0947630|[lbpr]|["studies"-tx-29-"studies"-noun-0]|TX|5946/7|
00000000|MMI|2.47|Treatment Plan|C0599880|[inpr]|["Plan"-tx-51-"PLAN"-noun-0]|TX|8301/4|
00000000|MMI|2.47|Due to|C0678226|[ftcn]|["Due To"-tx-39-"due to"-prep-0]|TX|6961/6|
00000000|MMI|2.46|Laboratory test finding|C0587081|[fndg]|["Labs"-tx-36-"labs"-noun-0]|TX|6647/4|
00000000|MMI|2.46|Multivitamin preparation|C0301532|[orch,phsu,vita]|["Multivitamin"-tx-4-"MULTIVITAMIN"-noun-0]|TX|1101/12|
00000000|MMI|2.46|Propine|C0138647|[orch,phsu]|["Propine"-tx-3-"PROPINE"-noun-0]|TX|523/7|
00000000|MMI|2.46|Chief complaint (finding)|C0277786|[fndg]|["complaints"-tx-8-"complaints"-noun-0]|TX|3813/10|
00000000|MMI|2.46|Instruction [Publication Type]|C0302828|[inpr]|["instructions"-tx-5-"Instructions"-noun-0]|TX|2580/12|
00000000|MMI|2.46|Instructions|C1442085|[idcn]|["Instructions"-tx-5-"Instructions"-noun-0]|TX|2580/12|
00000000|MMI|2.46|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-5-"Instructions"-noun-0]|TX|2580/12|
00000000|MMI|2.46|D-D mixture|C0112081|[hops,orch]|["D-D"-tx-45-"d d"-noun-0]|TX|7487/1,7491/1|
00000000|MMI|2.45|Agent|C0450442|[chvf]|["Agent"-tx-24-"agent"-noun-0]|TX|5509/5|
00000000|MMI|2.45|Pharmacologic Substance|C1254351|[phsu]|["Agent"-tx-24-"agent"-noun-0]|TX|5509/5|
00000000|MMI|2.45|Protocol Agent|C1521826|[inpr]|["Agent"-tx-24-"agent"-noun-0]|TX|5509/5|
00000000|MMI|2.45|0/5|C0444499|[qnco]|["0/5"-tx-37-"0.5"-real_number-0]|TX|6716/3|
00000000|MMI|2.45|End|C0444930|[spco]|["End"-tx-53-"END"-noun-0]|TX|8712/3|
00000000|MMI|2.45|NDUFB3 gene|C1417635|[gngm]|["B12"-tx-5-"B12"-noun-0]|TX|2468/3|
00000000|MMI|2.45|Responsible to|C1273518|[fndg]|["Responsible"-tx-7-"Responsible"-adj-0]|TX|3207/11|
00000000|MMI|2.45|TNFAIP1 gene|C1420797|[gngm]|["B12"-tx-5-"B12"-noun-0]|TX|2468/3|
00000000|MMI|2.45|TNFAIP1 wt Allele|C3538796|[gngm]|["B12"-tx-5-"B12"-noun-0]|TX|2468/3|
00000000|MMI|2.45|Trusopt|C0592218|[orch,phsu]|["Trusopt"-tx-5-"TRUSOPT"-noun-0]|TX|1490/7|
00000000|MMI|2.45|Metolazone 5 MG|C0987840|[clnd]|["Metolazone 5 MG"-tx-20-"5 mg Zaroxolyn"-noun-0]|TX|5082/4,5090/9|
00000000|MMI|2.45|Admission from|C1959907|[hlca]|["Admission from"-tx-34-"from admission"-adj-0]|TX|6429/4,6441/9|
00000000|MMI|2.44|Liquid diet|C0301571|[topp]|["Fluid diet"-tx-5-"fluid DIET"-noun-0]|TX|2756/10|
00000000|MMI|2.44|1 time|C3843309|[fndg]|["1 time"-tx-34-"1 time"-noun-1]|TX|6454/1,6461/4|
00000000|MMI|2.44|Re-admission|C1548168|[idcn]|["Re-admission"-tx-51-"admission re"-noun-0]|TX|8478/9,8502/2|
00000000|MMI|2.44|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-46-"cardiac"-adj-0]|TX|7564/7|
00000000|MMI|2.44|Conditional|C1701901|[qlco]|["Contingent"-tx-2-"CONTINGENT"-noun-0]|TX|281/10|
00000000|MMI|2.44|Evidence|C3887511|[idcn]|["Evidence"-tx-19-"evidence"-noun-0]|TX|4846/8|
00000000|MMI|2.44|Hospital environment|C1510665|[qlco]|["Hospital"-tx-27-"hospital"-noun-0]|TX|5789/8|
00000000|MMI|2.44|Lacking|C0332268|[qlco]|["lack"-tx-19-"lack"-noun-0]|TX|4814/4|
00000000|MMI|2.44|Night time|C0240526|[tmco]|["Night"-tx-27-"night"-noun-0]|TX|5693/5|
00000000|MMI|2.44|No Application Type|C1546968|[idcn]|["NA"-tx-46-"NA"-noun-0]|TX|7523/2|
00000000|MMI|2.44|contextual factors|C0542559|[ftcn]|["Setting"-tx-27-"setting"-noun-0]|TX|5798/7|
00000000|MMI|2.44|{Setting}|C1318139|[qnco]|["{Setting}"-tx-27-"setting"-noun-0]|TX|5798/7|
00000000|MMI|2.43|torsemide 100 MG|C0990871|[clnd]|["torsemide 100 MG"-tx-20-"100 mg torsemide"-noun-0]|TX|5051/6,5068/9|
00000000|MMI|2.43|Arikaree language|C1555622|[lang]|["Ris"-tx-47-"RISS"-noun-0]|TX|7633/4|
00000000|MMI|2.43|Concept model range (foundation metadata concept)|C3542016|[inpr]|["Range"-tx-23-"range"-noun-0]|TX|5442/5|
00000000|MMI|2.43|Disc - Body Part|C1556138|[bpoc]|["Disk"-tx-26-"disk"-noun-0]|TX|5640/4|
00000000|MMI|2.43|Disc Shape|C2348299|[spco]|["Disk"-tx-26-"disk"-noun-0]|TX|5640/4|
00000000|MMI|2.43|Disk Device Component|C1705229|[mnob]|["Disk"-tx-26-"disk"-noun-0]|TX|5640/4|
00000000|MMI|2.43|Disk Dosing Unit|C1705370|[qnco]|["{Disk}"-tx-26-"disk"-noun-0]|TX|5640/4|
00000000|MMI|2.43|Disks (device)|C0180459|[medd]|["DISC"-tx-26-"disk"-noun-0]|TX|5640/4|
00000000|MMI|2.43|Patient Class - Inpatient|C1549404|[idcn]|["Inpatient"-tx-47-"inpatient"-noun-0]|TX|7718/9|
00000000|MMI|2.43|Pounds|C0439219|[qnco]|["lbs"-tx-21-"lbs"-noun-0]|TX|5271/3|
00000000|MMI|2.43|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-39-"likely"-adv-0]|TX|6954/6|
00000000|MMI|2.43|Probably|C0750492|[idcn]|["Likely"-tx-39-"likely"-adv-0]|TX|6954/6|
00000000|MMI|2.43|RASL12 gene|C1428956|[gngm]|["RIS"-tx-47-"RISS"-noun-0]|TX|7633/4|
00000000|MMI|2.43|Range|C1514721|[qnco]|["Range"-tx-23-"range"-noun-0]|TX|5442/5|
00000000|MMI|2.43|Referral category - Inpatient|C1548438|[idcn]|["Inpatient"-tx-47-"inpatient"-noun-0]|TX|7718/9|
00000000|MMI|2.43|Sample Range|C2348147|[qnco]|["Range"-tx-23-"range"-noun-0]|TX|5442/5|
00000000|MMI|2.43|Variant|C0205419|[qlco]|["Variation"-tx-32-"variation"-noun-0]|TX|6240/9|
00000000|MMI|2.43|liquid-based cytology (procedure)|C3161851|[lbpr]|["LBS"-tx-21-"lbs"-noun-0]|TX|5271/3|
00000000|MMI|2.43|Acute-on-chronic|C0439588|[tmco]|["Acute-on-chronic"-tx-12-"acute on chronic"-adj-0]|TX|4239/16|
00000000|MMI|2.43|Make - Instruction Imperative|C1881534|[ftcn]|["Make"-tx-27-"made"-verb-0]|TX|5741/4|
00000000|MMI|2.43|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-41-"meds"-noun-0]|TX|7079/4|
00000000|MMI|2.43|PSMD4 wt Allele|C4049859|[gngm]|["AF"-tx-14-"AF"-noun-0]|TX|4313/2|
00000000|MMI|2.43|Per Nanoliter|C3892223|[qnco]|["/nL"-tx-37-"nl"-noun-0]|TX|6707/2|
00000000|MMI|2.43|Resolved|C3714811|[fndg]|["Resolved"-tx-34-"resolved"-verb-0]|TX|6420/8|
00000000|MMI|2.43|Resolved License|C3897700|[ftcn]|["Resolved"-tx-34-"resolved"-verb-0]|TX|6420/8|
00000000|MMI|2.43|Respiratory Domain|C2986904|[idcn]|["RE"-tx-23-"re"-verb-0]|TX|5403/2|
00000000|MMI|2.43|Retinol equivalents|C0556581|[qnco]|["{RE}"-tx-23-"re"-verb-0]|TX|5403/2|
00000000|MMI|2.43|Taken|C1883727|[cnce]|["Taken"-tx-41-"taken"-verb-0]|TX|7043/5|
00000000|MMI|2.43|Used by|C1273517|[fndg]|["used"-tx-2-"USED"-verb-1]|TX|330/4|
00000000|MMI|2.43|heparin, porcine|C0770546|[bacs,orch,phsu]|["HEPARIN"-tx-36-"Heparin"-noun-0]|TX|6540/7|
00000000|MMI|2.43|nanolitre|C0560008|[qnco]|["nL"-tx-37-"nl"-noun-0]|TX|6707/2|
00000000|MMI|2.43|Day 4|C3840892|[fndg]|["Day 4"-tx-20-"day 4"-noun-0]|TX|4939/3,4969/1|
00000000|MMI|2.42|% of total|C0439175|[qnco]|["% total"-tx-21-"total"-noun-0]|TX|5242/5|
00000000|MMI|2.42|Entity Name Part Type - given|C1550718|[idcn]|["given"-tx-5-"given"-verb-0]|TX|2737/5|
00000000|MMI|2.42|Feet, unit of measurement|C0347981|[qnco]|["feet"-tx-10-"feet"-noun-0]|TX|4077/4|
00000000|MMI|2.42|GIVEN|C1442162|[cnce]|["GIVEN"-tx-5-"given"-verb-0]|TX|2737/5|
00000000|MMI|2.42|Give - dosing instruction imperative|C1947971|[ftcn]|["Given"-tx-5-"given"-verb-0]|TX|2737/5|
00000000|MMI|2.42|Given name|C3244317|[inpr]|["given"-tx-5-"given"-verb-0]|TX|2737/5|
00000000|MMI|2.42|Loss|C1517945|[qnco]|["Loss"-tx-21-"loss"-noun-0]|TX|5248/4|
00000000|MMI|2.42|More|C0205172|[ftcn]|["More"-tx-10-"more"-adv-0]|TX|4063/4|
00000000|MMI|2.42|Total|C0439810|[qlco]|["Total"-tx-21-"total"-noun-0]|TX|5242/5|
00000000|MMI|2.42|ounce|C0439218|[qnco]|["OZ"-tx-5-"oz"-noun-0]|TX|2750/2|
00000000|MMI|2.42|((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1H-fluoren-7-yl)oxy)acetic acid|C0378071|[orch,phsu]|["b-3"-tx-5-"B-3"-adj-0]|TX|1320/3|
00000000|MMI|2.42|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-2-"D/C"-noun-0]|TX|317/3|
00000000|MMI|2.42|most likely|C0750501|[idcn]|["most likely"-tx-40-"Most likely"-adj-0]|TX|6981/11|
00000000|MMI|2.41|Issue (document)|C1706387|[inpr]|["Issue"-tx-24-"issues"-noun-0]|TX|5527/6|
00000000|MMI|2.41|Problem|C0033213|[fndg]|["Issue"-tx-24-"issues"-noun-1]|TX|5527/6|
00000000|MMI|2.40|Switch Device Component|C1707719|[mnob]|["Switch"-tx-20-"switched"-verb-0]|TX|5009/8|
00000000|MMI|2.39|Adjacent|C0205117|[spco]|["next"-tx-32-"next"-adj-0]|TX|6277/4|
00000000|MMI|2.39|Causing|C0678227|[ftcn]|["Causing"-tx-7-"Causing"-adj-0]|TX|3235/7|
00000000|MMI|2.39|DNLZ gene|C2239359|[gngm]|["HEP"-tx-38-"hep"-noun-0]|TX|6820/3|
00000000|MMI|2.39|Definite|C0439544|[qlco]|["Definite"-tx-4-"DEFINITE"-adj-0]|TX|848/8|
00000000|MMI|2.39|Definitely Related to Intervention|C1704787|[qlco]|["Definite"-tx-4-"DEFINITE"-adj-0]|TX|848/8|
00000000|MMI|2.39|Elevated|C3163633|[qlco]|["Elevated"-tx-47-"elevated"-adj-0]|TX|7742/8|
00000000|MMI|2.39|Genus Anemia|C1000483|[plnt]|["Anemia"-tx-28-"ANEMIA"-noun-0]|TX|5830/6|
00000000|MMI|2.39|HPSE wt Allele|C1705569|[gngm]|["HEP"-tx-38-"hep"-noun-0]|TX|6820/3|
00000000|MMI|2.39|High|C0205250|[qlco]|["Elevated"-tx-47-"elevated"-adj-0]|TX|7742/8|
00000000|MMI|2.39|Histamine Equivalent Prick Unit|C3891156|[qnco]|["HEP"-tx-38-"hep"-noun-0]|TX|6820/3|
00000000|MMI|2.39|Minimum|C1524031|[qlco]|["Trace"-tx-16-"trace"-noun-0]|TX|4455/5|
00000000|MMI|2.39|Negative|C0205160|[qlco]|["Negative"-tx-19-"negative"-adj-0]|TX|4887/8|
00000000|MMI|2.39|Negative Charge|C2825491|[qlco]|["Negative"-tx-19-"negative"-adj-0]|TX|4887/8|
00000000|MMI|2.39|Negative Finding|C1513916|[fndg]|["NEGATIVE"-tx-19-"negative"-adj-1]|TX|4887/8|
00000000|MMI|2.39|Negative Number|C2825415|[cnce]|["Negative"-tx-19-"negative"-adj-0]|TX|4887/8|
00000000|MMI|2.39|Peak level|C0444505|[qnco]|["Peak"-tx-37-"peak"-adj-0]|TX|6658/4|
00000000|MMI|2.39|Progressive|C0205329|[ftcn]|["Progressive"-tx-9-"progressive"-adj-0]|TX|3952/11|
00000000|MMI|2.39|Sequence Chromatogram|C1883002|[ftcn]|["Trace"-tx-16-"trace"-noun-0]|TX|4455/5|
00000000|MMI|2.39|Stat (do immediately)|C0205548|[tmco]|["Immediately"-tx-50-"immediately"-adv-0]|TX|8253/11|
00000000|MMI|2.39|Yes (indicator)|C1705108|[cnce]|["YES"-tx-2-"YES"-noun-0]|TX|355/3|
00000000|MMI|2.39|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-2-"YES"-noun-0]|TX|355/3|
00000000|MMI|2.39|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-52-"dictated"-adj-0]|TX|8622/8|
00000000|MMI|2.39|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-52-"dictated"-adj-0]|TX|8622/8|
00000000|MMI|2.39|trace amount|C0442822|[qnco]|["Trace"-tx-16-"trace"-noun-0]|TX|4455/5|
00000000|MMI|2.39|mg/mg|C1319635|[qnco]|["mg/mg"-tx-5-"MG MG"-noun-0]|TX|1456/2,1480/2|
00000000|MMI|2.38|Million|C1881839|[qnco]|["10^6"-tx-1-"10/6"-fraction-0]|TX|108/4|
00000000|MMI|2.38|5/5|C0450380|[qnco]|["5/5"-tx-3-"5 5"-integer-0]|TX|726/1,748/1|
00000000|MMI|2.38|Administration procedure|C1533734|[topp]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|3340/9|
00000000|MMI|2.38|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|3340/9|
00000000|MMI|2.38|Blood group antibody I|C0221138|[aapp,imft]|["I NOS"-tx-22-"I"-noun-0]|TX|5323/1|
00000000|MMI|2.38|Dietary Route of Administration|C2699635|[ftcn]|["DIETARY"-tx-11-"dietary"-adj-0]|TX|4161/7|
00000000|MMI|2.38|Event Seriousness - Significant|C1546944|[qlco]|["Significant"-tx-45-"significant"-adj-0]|TX|7442/11|
00000000|MMI|2.38|Full|C0443225|[qlco]|["Full"-tx-3-"Full"-adj-0]|TX|415/4|
00000000|MMI|2.38|Possible|C0332149|[qlco]|["Possible"-tx-4-"POSSIBLE"-adj-0]|TX|913/8|
00000000|MMI|2.38|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-4-"POSSIBLE"-adj-0]|TX|913/8|
00000000|MMI|2.38|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-4-"POSSIBLE"-adj-0]|TX|913/8|
00000000|MMI|2.38|Post|C0687676|[tmco]|["Post"-tx-9-"Post"-noun-0]|TX|3891/4|
00000000|MMI|2.38|Post Device Component|C1704687|[mnob]|["Post"-tx-9-"Post"-noun-0]|TX|3891/4|
00000000|MMI|2.38|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-5-"regular exercise"-noun-0]|TX|2943/16|
00000000|MMI|2.38|Significant|C0750502|[idcn]|["Significant"-tx-45-"significant"-adj-0]|TX|7442/11|
00000000|MMI|2.38|Statistical Significance|C0237881|[qnco]|["significant"-tx-45-"significant"-adj-0]|TX|7442/11|
00000000|MMI|2.38|Treating|C1522326|[ftcn]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|3340/9|
00000000|MMI|2.38|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-7-"Treatment"-noun-0]|TX|3340/9|
00000000|MMI|2.38|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-7-"Treatment"-noun-0]|TX|3340/9|
00000000|MMI|2.37|Tamoxifen 20 MG|C1126289|[clnd]|["Tamoxifen 20 MG"-tx-5-"TAMOXIFEN 20 MG"-noun-0]|TX|2446/15|
00000000|MMI|2.37|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-29-"3"-integer-0]|TX|5904/1|
00000000|MMI|2.37|3+ Score|C2827736|[qnco]|["3+"-tx-29-"3"-integer-0]|TX|5904/1|
00000000|MMI|2.37|3+ Score, WHO|C2981702|[clas]|["3+"-tx-29-"3"-integer-0]|TX|5904/1|
00000000|MMI|2.37|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-29-"3"-integer-0]|TX|5904/1|
00000000|MMI|2.37|HPS4 gene|C1423767|[gngm]|["LE"-tx-17-"LE"-noun-0]|TX|4487/2|
00000000|MMI|2.37|LE, Rat Strain|C2697858|[mamm]|["LE"-tx-17-"LE"-noun-0]|TX|4487/2|
00000000|MMI|2.37|Less Than or Equal to|C0439090|[qnco]|["LE"-tx-17-"LE"-noun-0]|TX|4487/2|
00000000|MMI|2.37|Sodium Drug Class|C3714642|[phsu]|["SODIUM"-tx-5-"Sodium"-noun-0]|TX|2919/6|
00000000|MMI|2.37|Sodium supplements|C3541959|[phsu]|["Sodium"-tx-5-"Sodium"-noun-0]|TX|2919/6|
00000000|MMI|2.37|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-4-"TAB"-noun-0]|TX|1155/3|
00000000|MMI|2.37|gram|C0439208|[qnco]|["GRAM"-tx-5-"gram"-noun-0]|TX|2914/4|
00000000|MMI|2.37|Chronic atrial fibrillation|C0694539|[dsyn]|["Chronic AFib"-tx-24-"chronic afib"-noun-0]|TX|5472/12|
00000000|MMI|2.37|rate control|C0489879|[ftcn]|["Rate control"-tx-24-"rate control"-noun-0]|TX|5492/12|
00000000|MMI|2.36|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|86/3|
00000000|MMI|2.36|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-3-"QHS"-noun-0]|TX|648/3|
00000000|MMI|2.36|Osa <plant>|C1656862|[plnt]|["Osa"-tx-7-"OSA"-noun-0]|TX|3716/3|
00000000|MMI|2.36|Primary|C0205225|[qlco]|["Principal"-tx-7-"PRINCIPAL"-adj-0]|TX|3176/9|
00000000|MMI|2.36|Teaching principal|C0401925|[prog]|["Principal"-tx-7-"PRINCIPAL"-adj-0]|TX|3176/9|
00000000|MMI|2.36|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-5-"ADA"-noun-0]|TX|2889/3|
00000000|MMI|2.36|CA8 gene|C1413051|[gngm]|["CALS"-tx-5-"cals"-noun-0]|TX|2898/4|
00000000|MMI|2.36|Genus Ada|C1060325|[plnt]|["Ada"-tx-5-"ADA"-noun-0]|TX|2889/3|
00000000|MMI|2.36|HORNS IN SHEEP|C1832110|[fndg]|["HO"-tx-2-"Ho"-noun-0]|TX|223/2|
00000000|MMI|2.36|Healthcare Encounters Domain|C3889614|[inpr]|["HO"-tx-2-"Ho"-noun-0]|TX|223/2|
00000000|MMI|2.36|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-5-"cals"-noun-0]|TX|2898/4|
00000000|MMI|2.36|Similarity|C2348205|[qlco]|["Similar"-tx-8-"similar"-adj-0]|TX|3805/7|
00000000|MMI|2.36|Study Day|C2826182|[tmco]|["DY"-tx-5-"dy"-noun-0]|TX|2903/2|
00000000|MMI|2.36|kilocalorie|C0439259|[qnco]|["Cal"-tx-5-"cals"-noun-0]|TX|2898/4|
00000000|MMI|2.36|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-5-"chol"-noun-0]|TX|2856/4|
00000000|MMI|2.36|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-5-"sat"-noun-0]|TX|2865/3|
00000000|MMI|2.36|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-5-"sat"-noun-0]|TX|2865/3|
00000000|MMI|2.36|HL7PublishingSubSection <practice>|C3245512|[inpr]|["practice"-tx-11-"practiced"-adj-0]|TX|4151/9|
00000000|MMI|2.36|Practice Experience|C0237607|[menp]|["practice"-tx-11-"practiced"-adj-0]|TX|4151/9|
00000000|MMI|2.36|liter|C0475211|[qnco]|["LITER"-tx-5-"liters"-noun-0]|TX|2831/6|
00000000|MMI|2.36|Hospital course|C0489547|[fndg]|["Hospital course"-tx-7-"HOSPITAL COURSE"-noun-1]|TX|3606/15|
00000000|MMI|2.36|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-7-"HOSPITAL COURSE"-noun-0]|TX|3606/15|
00000000|MMI|2.36|Room of building - Study|C0557651|[mnob]|["Study"-tx-7-"Study"-noun-0]|TX|3225/5|
00000000|MMI|2.36|Study|C2603343|[resa]|["Study"-tx-7-"Study"-noun-0]|TX|3225/5|
00000000|MMI|2.36|Alert|C3665546|[ftcn]|["Alert"-tx-3-"Alert"-noun-0]|TX|769/5|
00000000|MMI|2.36|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-3-"Alert"-noun-0]|TX|769/5|
00000000|MMI|2.36|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-3-"Alert"-noun-0]|TX|769/5|
00000000|MMI|2.36|Every six hours|C0585325|[tmco]|["Q6H"-tx-3-"Q6H"-noun-0]|TX|756/3|
00000000|MMI|2.36|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-3-"Pain"-noun-0]|TX|764/4|
00000000|MMI|2.36|6 Hours|C1292428|[tmco]|["6H"-tx-5-"6H"-noun-0]|TX|2362/2|
00000000|MMI|2.36|Inhaler Dosing Unit|C1881212|[qnco]|["INHALER"-tx-5-"INHALER"-noun-0]|TX|2336/7|
00000000|MMI|2.36|hospital admission rate|C0598610|[qnco]|["Admission rate"-tx-24-"rate admission"-noun-0]|TX|5522/4,5546/9|
00000000|MMI|2.35|Liver enzyme|C0443764|[aapp,enzy]|["Liver enzyme"-tx-49-"liver enzyme"-noun-0]|TX|8042/12|
00000000|MMI|2.35|TSPAN1 gene|C1540081|[gngm]|["NET-1"-tx-21-"net 1"-adj-0]|TX|5238/3,5258/1|
00000000|MMI|2.35|To doctor|C3846009|[fndg]|["To doctor"-tx-31-"to doctor"-noun-0]|TX|6053/2,6078/6|
00000000|MMI|2.35|1-2|C3843716|[fndg]|["1-2"-tx-5-"1-2"-integer-0]|TX|1612/3|
00000000|MMI|2.35|1/2|C0580272|[inpr]|["1/2"-tx-5-"1-2"-integer-0]|TX|1612/3|
00000000|MMI|2.35|Before|C0332152|[tmco]|["Prior to"-tx-20-"prior to"-prep-0]|TX|5111/8|
00000000|MMI|2.35|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-2-"CAR"-noun-0]|TX|235/3|
00000000|MMI|2.35|Cardiologist|C0175906|[prog]|["Cardiologist"-tx-48-"cardiologist"-noun-0]|TX|7847/12|
00000000|MMI|2.35|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-19-"CV"-noun-0]|TX|4834/2|
00000000|MMI|2.35|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-2-"CAR"-noun-0]|TX|235/3|
00000000|MMI|2.35|Decreased|C0205216|[qnco]|["Decreased"-tx-33-"decreased"-adj-0]|TX|6377/9|
00000000|MMI|2.35|Decreasing|C0442797|[qlco]|["decreased"-tx-33-"decreased"-adj-0]|TX|6377/9|
00000000|MMI|2.35|Extensive|C0205231|[qlco]|["Extensive"-tx-7-"extensive"-adj-0]|TX|3632/9|
00000000|MMI|2.35|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-2-"PM"-adj-0]|TX|278/2|
00000000|MMI|2.35|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-2-"CAR"-noun-0]|TX|235/3|
00000000|MMI|2.35|Phase I/II Trial|C1519043|[resa]|["1-2"-tx-5-"1-2"-integer-0]|TX|1612/3|
00000000|MMI|2.35|Reduced|C0392756|[qlco]|["Decreased"-tx-33-"decreased"-adj-0]|TX|6377/9|
00000000|MMI|2.35|good effect|C0541990|[fndg]|["GOOD EFFECT"-tx-20-"good effect"-noun-0]|TX|5141/4,5155/6|
00000000|MMI|2.35|Percent Mass per Mass|C1709500|[qnco]|["%{w/w}"-tx-18-"w w"-adj-0]|TX|4552/1,4590/1|
00000000|MMI|2.35|Weight/weight ratio|C2919747|[qnco]|["w/w"-tx-18-"w w"-adj-0]|TX|4552/1,4590/1|
00000000|MMI|2.35|Present|C0150312|[qnco]|["Present"-tx-12-"present"-adj-0]|TX|4192/7|
00000000|MMI|2.35|Resolution Property|C1706463|[qnco]|["Resolution"-tx-32-"resolution"-noun-0]|TX|6259/10|
00000000|MMI|2.34|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-7-"BRIEF"-adj-0]|TX|3590/5|
00000000|MMI|2.34|Brief|C1879313|[tmco]|["Brief"-tx-7-"BRIEF"-adj-0]|TX|3590/5|
00000000|MMI|2.34|Character String Data Type|C3272372|[inpr]|["ST"-tx-14-"ST"-adj-0]|TX|4324/2|
00000000|MMI|2.34|Shortened|C1282927|[qlco]|["brief"-tx-7-"BRIEF"-adj-0]|TX|3590/5|
00000000|MMI|2.34|Kilogram|C0439209|[qnco]|["kg"-tx-21-"kg"-noun-0]|TX|5260/2|
00000000|MMI|2.34|Per Kilogram|C4054209|[qnco]|["/kg"-tx-21-"kg"-noun-0]|TX|5260/2|
00000000|MMI|2.34|Spray (action)|C2003858|[ftcn]|["Spray"-tx-5-"SPRAY"-noun-0]|TX|1616/5|
00000000|MMI|2.34|Spray Dosing Unit|C1704413|[qnco]|["{Spray}"-tx-5-"SPRAY"-noun-0]|TX|1616/5|
00000000|MMI|2.34|Discharge from hospital|C0586003|[hlca]|["hospital Release"-tx-5-"hospital RELEASE"-noun-0]|TX|2617/8,2650/7|
00000000|MMI|2.34|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-18-"now"-adv-0]|TX|4584/3|
00000000|MMI|2.34|Recent|C0332185|[tmco]|["Recent"-tx-18-"recent"-adj-0]|TX|4560/6|
00000000|MMI|2.34|Gently|C1638411|[qlco]|["Gently"-tx-20-"gently"-adv-0]|TX|4919/6|
00000000|MMI|2.33|% release (qualifier value)|C0439180|[qnco]|["% release"-tx-5-"RELEASE"-adj-0]|TX|2650/7|
00000000|MMI|2.33|Diabetes|C0011847|[dsyn]|["Diabetes"-tx-5-"diabetes"-noun-0]|TX|2626/8|
00000000|MMI|2.33|Discharge (release)|C0680255|[hlca]|["release"-tx-5-"RELEASE"-adj-0]|TX|2650/7|
00000000|MMI|2.33|Intellectual scale|C0349674|[inpr]|["Scale"-tx-5-"scale"-noun-0]|TX|2635/5|
00000000|MMI|2.33|Release (procedure)|C1963578|[topp]|["Release"-tx-5-"RELEASE"-adj-0]|TX|2650/7|
00000000|MMI|2.33|Release - action (qualifier value)|C1283071|[ftcn]|["Release"-tx-5-"RELEASE"-adj-0]|TX|2650/7|
00000000|MMI|2.33|Re